Left ventricular hypertrophy and hypertension

Hypertension (HTN) is a major modifiable risk factor for cardiovascular disease (CVD) morbidity and mortality. The left ventricle (LV) is a primary target for HTN end-organ damage. In addition to being a marker of HTN, LV geometrical changes: concentric remodeling, concentric or eccentric LV hypertr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Progress in cardiovascular diseases Ročník 63; číslo 1; s. 10 - 21
Hlavní autoři: Yildiz, Mehmet, Oktay, Ahmet Afşin, Stewart, Merrill H., Milani, Richard V., Ventura, Hector O., Lavie, Carl J.
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States Elsevier Inc 01.01.2020
Témata:
Anti-hypertension therapy
Antihypertensive Agents - therapeutic use
Blood Pressure - drug effects
Cardiovascular
Humans
Hypertension
Hypertension - diagnosis
Hypertension - mortality
Hypertension - physiopathology
Hypertension - therapy
Hypertrophy, Left Ventricular - diagnostic imaging
Hypertrophy, Left Ventricular - mortality
Hypertrophy, Left Ventricular - physiopathology
Hypertrophy, Left Ventricular - prevention & control
Left ventricular geometry
Left ventricular hypertrophy
Remodeling
Risk Factors
Risk Reduction Behavior
Treatment Outcome
Ventricular Function, Left - drug effects
Ventricular Remodeling - drug effects
MESA
RCT
HTN
MRI
STE
RAAS
DM
LV
Remodeling
BP
CCBs
CACS
2D
ASE
CHIP
ESC
ARIC
cLVH
eLVH
ESH
Anti-hypertension therapy
MI
CKD
HOPE
LIFE
SBP
Hypertension
ACC
EF
ACE
AF
SGLT2
ALLHAT
CAD
ECG
Left ventricular geometry
RWT
CR
CVD
EACVI
3D
HCM
SCD
Left ventricular hypertrophy
AHA
ARBs
HF
LVH
Myocardial infarction
Randomized clinical trial
Angiotensin receptor blockers
European Society of Hypertension
Cardiovascular disease
Left ventricle/ventricular
Calcium channel blockers
Electrocardiography
Blood pressure
Renin-angiotensin-aldosterone system
Concentric left ventricular hypertrophy
Sodium-glucose cotransporter type2
Heart failure
Systolic blood pressure
American College of Cardiology
American Heart Association
Multiethnic Study of Atherosclerosis
Angiotensin converting enzyme
Losartan Intervention for Endpoint Reduction
Hypertrophic cardiomyopathy
American Society of Echocardiography
Ejection fraction
Atherosclerosis Risk in Communities
Heart Outcomes Prevention Evaluation
Eccentric left ventricular hypertrophy
European Association of Cardiovascular Imaging
Two-dimensional
Relative wall thickness
Chlorthalidone, indapamide, and potassium-sparing diuretic/hydrochlorothiazide
Coronary artery calcium scoring
Atrial fibrillation
Concentric remodeling
Diabetes mellitus
Speckle tracking echocardiography
Chronic kidney disease
Sudden cardiac death
Coronary artery disease
Hypertension or hypertensive
European Society of Cardiology
Magnetic resonance imaging
Three-dimensional
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack
ISSN:0033-0620, 1873-1740, 1532-8643, 1873-1740
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Hypertension (HTN) is a major modifiable risk factor for cardiovascular disease (CVD) morbidity and mortality. The left ventricle (LV) is a primary target for HTN end-organ damage. In addition to being a marker of HTN, LV geometrical changes: concentric remodeling, concentric or eccentric LV hypertrophy (LVH) are major independent risk factors for not only CVD morbidity and mortality but also for all-cause mortality and neurological pathologies. Blood pressure control with lifestyle changes and antihypertensive agents has been demonstrated to prevent and regress LVH. Herein, we provide a comprehensive review of literature on the relationship between HTN and LV geometry abnormalities with a focus on diagnosis, prognosis, pathophysiological mechanisms, and treatment approaches.
AbstractList Hypertension (HTN) is a major modifiable risk factor for cardiovascular disease (CVD) morbidity and mortality. The left ventricle (LV) is a primary target for HTN end-organ damage. In addition to being a marker of HTN, LV geometrical changes: concentric remodeling, concentric or eccentric LV hypertrophy (LVH) are major independent risk factors for not only CVD morbidity and mortality but also for all-cause mortality and neurological pathologies. Blood pressure control with lifestyle changes and antihypertensive agents has been demonstrated to prevent and regress LVH. Herein, we provide a comprehensive review of literature on the relationship between HTN and LV geometry abnormalities with a focus on diagnosis, prognosis, pathophysiological mechanisms, and treatment approaches.
AbstractHypertension (HTN) is a major modifiable risk factor for cardiovascular disease (CVD) morbidity and mortality. The left ventricle (LV) is a primary target for HTN end-organ damage. In addition to being a marker of HTN, LV geometrical changes: concentric remodeling, concentric or eccentric LV hypertrophy (LVH) are major independent risk factors for not only CVD morbidity and mortality but also for all-cause mortality and neurological pathologies. Blood pressure control with lifestyle changes and antihypertensive agents has been demonstrated to prevent and regress LVH. Herein, we provide a comprehensive review of literature on the relationship between HTN and LV geometry abnormalities with a focus on diagnosis, prognosis, pathophysiological mechanisms, and treatment approaches.
Hypertension (HTN) is a major modifiable risk factor for cardiovascular disease (CVD) morbidity and mortality. The left ventricle (LV) is a primary target for HTN end-organ damage. In addition to being a marker of HTN, LV geometrical changes: concentric remodeling, concentric or eccentric LV hypertrophy (LVH) are major independent risk factors for not only CVD morbidity and mortality but also for all-cause mortality and neurological pathologies. Blood pressure control with lifestyle changes and antihypertensive agents has been demonstrated to prevent and regress LVH. Herein, we provide a comprehensive review of literature on the relationship between HTN and LV geometry abnormalities with a focus on diagnosis, prognosis, pathophysiological mechanisms, and treatment approaches.Hypertension (HTN) is a major modifiable risk factor for cardiovascular disease (CVD) morbidity and mortality. The left ventricle (LV) is a primary target for HTN end-organ damage. In addition to being a marker of HTN, LV geometrical changes: concentric remodeling, concentric or eccentric LV hypertrophy (LVH) are major independent risk factors for not only CVD morbidity and mortality but also for all-cause mortality and neurological pathologies. Blood pressure control with lifestyle changes and antihypertensive agents has been demonstrated to prevent and regress LVH. Herein, we provide a comprehensive review of literature on the relationship between HTN and LV geometry abnormalities with a focus on diagnosis, prognosis, pathophysiological mechanisms, and treatment approaches.
Author Milani, Richard V.
Stewart, Merrill H.
Yildiz, Mehmet
Oktay, Ahmet Afşin
Lavie, Carl J.
Ventura, Hector O.
Author_xml – sequence: 1
  givenname: Mehmet
  surname: Yildiz
  fullname: Yildiz, Mehmet
  organization: Department of Medicine, Southern Ohio Medical Center, Portsmouth, OH, United States of America
– sequence: 2
  givenname: Ahmet Afşin
  surname: Oktay
  fullname: Oktay, Ahmet Afşin
  email: ahmet.oktay@wdhospital.org
  organization: Department of Medicine, Division of Cardiology, Wentworth-Douglass Hospital, Partners HealthCare, Dover, NH, United States of America
– sequence: 3
  givenname: Merrill H.
  surname: Stewart
  fullname: Stewart, Merrill H.
  organization: Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School - The University of Queensland School of Medicine, New Orleans, LA, United States of America
– sequence: 4
  givenname: Richard V.
  surname: Milani
  fullname: Milani, Richard V.
  organization: Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School - The University of Queensland School of Medicine, New Orleans, LA, United States of America
– sequence: 5
  givenname: Hector O.
  surname: Ventura
  fullname: Ventura, Hector O.
  organization: Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School - The University of Queensland School of Medicine, New Orleans, LA, United States of America
– sequence: 6
  givenname: Carl J.
  surname: Lavie
  fullname: Lavie, Carl J.
  organization: Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School - The University of Queensland School of Medicine, New Orleans, LA, United States of America
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31759953$$D View this record in MEDLINE/PubMed
BookMark eNqFkU9r3DAQxUVJaTZpv0APZY-92J2RZNkupRBC_8FCD81dyPKYaOuVXUkO7LevzG4ugaYXDYL3ezPz5opd-MkTY28RSgRUH_blbE1fcsC2RCwB2hdsg5XgRaOkuGAbACEKUBwu2VWMewCsoK5fsUuBddW2ldiwYkdD2j6QT8HZZTRhe3-cKaQwzffHrfH9-U8-usm_Zi8HM0Z6c67X7O7rl7vb78Xu57cftze7wkrFU4FNdu8kNrXMT6VaIWo5QNPzoaemHpATdIPqemqV7Spbi8qCzNNS1XTGimv2_mQ7h-nPQjHpg4uWxtF4mpaoeZ6_VSgVZOm7s3TpDtTrObiDCUf9uGEWNCeBDVOMgQZtXTIpL5OCcaNG0GuYeq_XMPUapkbUOcyM8ifoo_uz0KcTRDmfB0dBR-vIW-pdIJt0P7nn8c9PcDs676wZf9OR4n5ags_Ja9SRa9C_1hOvF8ZWAEohs8HHfxv8r_tfZpi0Og
CitedBy_id crossref_primary_10_1097_HJH_0000000000003885
crossref_primary_10_1038_s41371_021_00505_8
crossref_primary_10_1161_HYPERTENSIONAHA_124_23497
crossref_primary_10_3390_ph15070819
crossref_primary_10_1016_j_ejphar_2023_176252
crossref_primary_10_3390_ijms23042263
crossref_primary_10_3389_fcvm_2021_715491
crossref_primary_10_1093_jb_mvab100
crossref_primary_10_3389_fped_2021_722385
crossref_primary_10_1097_MBP_0000000000000748
crossref_primary_10_1016_j_jrras_2022_07_011
crossref_primary_10_1155_2024_7858899
crossref_primary_10_1111_jch_14863
crossref_primary_10_2174_0109298673274823231220063652
crossref_primary_10_3390_clinpract15070126
crossref_primary_10_7759_cureus_44150
crossref_primary_10_1016_j_matdes_2025_114288
crossref_primary_10_1126_science_abn6598
crossref_primary_10_1016_j_diabres_2022_109884
crossref_primary_10_1097_GME_0000000000001884
crossref_primary_10_1016_j_intimp_2023_110072
crossref_primary_10_1007_s00392_025_02647_y
crossref_primary_10_1186_s12872_021_02055_w
crossref_primary_10_1080_14728222_2022_2031974
crossref_primary_10_1002_ehf2_13415
crossref_primary_10_3389_fphys_2020_00967
crossref_primary_10_1136_bmjopen_2023_075087
crossref_primary_10_1016_j_pcad_2022_01_011
crossref_primary_10_3389_fcvm_2022_992284
crossref_primary_10_1186_s40360_021_00498_7
crossref_primary_10_1055_a_2096_5114
crossref_primary_10_1177_2050313X221141796
crossref_primary_10_1016_j_mvr_2025_104843
crossref_primary_10_1016_j_chemosphere_2022_136576
crossref_primary_10_1016_j_joim_2024_05_002
crossref_primary_10_2147_NDT_S408812
crossref_primary_10_1186_s12944_024_02282_y
crossref_primary_10_1007_s10554_024_03183_y
crossref_primary_10_1111_jch_14047
crossref_primary_10_1016_j_envpol_2025_126009
crossref_primary_10_1038_s41598_022_15818_y
crossref_primary_10_1038_s41598_021_85817_y
crossref_primary_10_1038_s44161_025_00656_8
crossref_primary_10_1016_j_nut_2022_111726
crossref_primary_10_1155_2022_9494981
crossref_primary_10_1038_s41598_023_36447_z
crossref_primary_10_2196_71850
crossref_primary_10_1007_s12012_024_09913_x
crossref_primary_10_2174_011573403X357558250122062037
crossref_primary_10_1016_j_numecd_2023_05_010
crossref_primary_10_1097_HJH_0000000000004074
crossref_primary_10_26724_2079_8334_2025_1_91_26_31
crossref_primary_10_1016_j_freeradbiomed_2021_02_012
crossref_primary_10_15829_1560_4071_2024_5654
crossref_primary_10_1038_s41371_022_00657_1
crossref_primary_10_38103_jcmhch_16_8_10
crossref_primary_10_1007_s00018_023_04987_2
crossref_primary_10_1186_s12929_021_00730_w
crossref_primary_10_1111_anec_13086
crossref_primary_10_1177_09732179231151754
crossref_primary_10_1159_000529903
crossref_primary_10_1016_j_cca_2023_117226
crossref_primary_10_1111_jch_13973
crossref_primary_10_1016_j_ijcard_2022_08_033
crossref_primary_10_1007_s12144_022_03601_1
crossref_primary_10_3389_fcvm_2025_1533707
crossref_primary_10_1016_j_clinbiochem_2024_110766
crossref_primary_10_1155_2021_7262776
crossref_primary_10_1016_j_jep_2024_118896
crossref_primary_10_2147_DDDT_S494555
crossref_primary_10_1097_RHU_0000000000001884
crossref_primary_10_1155_ijhy_2618127
crossref_primary_10_1155_2022_6652028
crossref_primary_10_1016_j_jacc_2023_03_419
crossref_primary_10_3390_jcm10071514
crossref_primary_10_3390_hearts6030018
crossref_primary_10_1038_s41598_025_97880_w
crossref_primary_10_1111_ctr_14742
crossref_primary_10_1016_j_omtn_2022_07_018
crossref_primary_10_1038_s41440_024_01617_7
crossref_primary_10_1038_s41598_025_09054_3
crossref_primary_10_3389_fcvm_2022_882077
crossref_primary_10_3390_jcm11216342
crossref_primary_10_7759_cureus_28003
crossref_primary_10_1016_j_pcad_2021_09_004
crossref_primary_10_1002_jcu_23408
crossref_primary_10_1097_HJH_0000000000002898
crossref_primary_10_3390_molecules28031369
crossref_primary_10_1080_27697061_2025_2461217
crossref_primary_10_1002_jcu_24055
crossref_primary_10_1161_JAHA_124_038108
crossref_primary_10_3390_jcm14165812
crossref_primary_10_1111_jch_14240
crossref_primary_10_1155_2021_6631500
crossref_primary_10_1007_s11332_021_00836_6
crossref_primary_10_1016_j_pcad_2021_09_003
crossref_primary_10_1186_s12947_021_00257_y
crossref_primary_10_1080_08037051_2025_2517122
crossref_primary_10_3390_healthcare9081066
crossref_primary_10_3390_jcdd10060236
crossref_primary_10_2147_IJGM_S412230
crossref_primary_10_3389_fcvm_2023_1236730
crossref_primary_10_1039_D3FO01737K
crossref_primary_10_1111_jch_14595
crossref_primary_10_1007_s00726_023_03331_z
crossref_primary_10_1007_s10396_024_01456_6
crossref_primary_10_1111_jch_70003
crossref_primary_10_3390_nu16234079
crossref_primary_10_1097_HJH_0000000000003003
crossref_primary_10_1038_s41598_024_81611_8
crossref_primary_10_3390_jcdd12080317
crossref_primary_10_1093_ajh_hpab067
crossref_primary_10_1155_2021_9993060
crossref_primary_10_1002_cpt_2635
crossref_primary_10_15857_ksep_2023_00388
crossref_primary_10_1016_j_puhe_2025_03_012
crossref_primary_10_1038_s41366_024_01474_x
crossref_primary_10_1016_j_jmps_2025_106349
crossref_primary_10_1007_s40119_022_00260_y
crossref_primary_10_1016_j_jhazmat_2023_131832
crossref_primary_10_1038_s41440_024_01608_8
crossref_primary_10_1093_ajh_hpae105
crossref_primary_10_3389_fphar_2022_826669
crossref_primary_10_1111_sms_70124
crossref_primary_10_3389_fendo_2022_910575
crossref_primary_10_3390_ijms23158167
crossref_primary_10_1007_s00330_023_10100_9
crossref_primary_10_1111_cpf_12789
crossref_primary_10_3389_fphys_2022_866792
crossref_primary_10_1038_s41598_022_12359_2
crossref_primary_10_1055_a_1690_3566
crossref_primary_10_1016_j_ecoenv_2021_112659
crossref_primary_10_1016_j_bcp_2023_115462
crossref_primary_10_1186_s11658_022_00349_1
crossref_primary_10_3389_fcvm_2022_929792
crossref_primary_10_1002_cnm_3906
crossref_primary_10_1016_j_jpsychores_2024_111944
crossref_primary_10_3390_antiox10111803
crossref_primary_10_15829_1728_8800_2025_4117
crossref_primary_10_1186_s12872_022_02463_6
crossref_primary_10_1016_j_compbiomed_2024_109019
crossref_primary_10_1016_j_jss_2022_04_054
crossref_primary_10_3389_fendo_2022_1079043
crossref_primary_10_1051_bioconf_202413801019
crossref_primary_10_1161_JAHA_123_033521
crossref_primary_10_1016_j_jacadv_2025_101721
crossref_primary_10_1111_jch_14328
crossref_primary_10_1186_s12911_024_02666_1
crossref_primary_10_1590_1414_431x2024e14210
crossref_primary_10_3390_jcm14093121
crossref_primary_10_1161_JAHA_122_027004
crossref_primary_10_1161_JAHA_122_028568
crossref_primary_10_1038_s41598_023_27590_8
crossref_primary_10_1016_j_pcad_2021_01_002
crossref_primary_10_3389_fendo_2023_1260050
crossref_primary_10_1097_HCO_0000000000001135
crossref_primary_10_3389_fphys_2022_920196
crossref_primary_10_1016_S2213_8587_20_30342_9
crossref_primary_10_1080_10641963_2022_2055764
crossref_primary_10_3389_fcvm_2022_993513
crossref_primary_10_3390_diagnostics12020543
crossref_primary_10_3390_jpm14060558
crossref_primary_10_1155_2021_9938486
crossref_primary_10_1016_j_foodres_2025_116418
crossref_primary_10_1016_j_pcad_2021_07_012
crossref_primary_10_7759_cureus_15592
crossref_primary_10_26599_1671_5411_2023_02_007
crossref_primary_10_3724_abbs_2024181
crossref_primary_10_1111_jch_14786
crossref_primary_10_1007_s00117_022_01068_6
crossref_primary_10_1111_jch_14301
crossref_primary_10_1186_s12872_025_04470_9
crossref_primary_10_3389_fimmu_2024_1467089
crossref_primary_10_1038_s41440_022_01075_z
crossref_primary_10_1097_HJH_0000000000002586
crossref_primary_10_2147_IBPC_S324151
crossref_primary_10_1002_pdi3_92
crossref_primary_10_1038_s41371_022_00751_4
crossref_primary_10_3389_fped_2021_620158
crossref_primary_10_3389_fphar_2021_716884
crossref_primary_10_3390_nu13093267
crossref_primary_10_7759_cureus_30842
crossref_primary_10_3390_ijms25042344
crossref_primary_10_1016_j_bbadis_2024_167113
crossref_primary_10_3390_pharmaceutics15051408
crossref_primary_10_1016_j_pcad_2022_08_005
crossref_primary_10_3892_etm_2024_12508
crossref_primary_10_33667_2078_5631_2025_18_19_23
crossref_primary_10_1016_j_mayocp_2022_06_018
crossref_primary_10_3389_fcvm_2022_1006380
crossref_primary_10_1097_FJC_0000000000001220
crossref_primary_10_1161_JAHA_121_021307
crossref_primary_10_3390_jcm13092708
crossref_primary_10_3390_nu15245021
crossref_primary_10_3389_fcvm_2021_681572
crossref_primary_10_1038_s41430_025_01623_z
crossref_primary_10_1016_j_cellsig_2023_110974
crossref_primary_10_15758_ajk_2025_27_2_36
crossref_primary_10_1039_D4FO04251D
crossref_primary_10_7759_cureus_33429
crossref_primary_10_1016_j_amjcard_2022_07_027
crossref_primary_10_1016_j_jacc_2020_10_031
crossref_primary_10_1088_1361_6579_adfc25
crossref_primary_10_3389_fphar_2024_1398630
crossref_primary_10_1016_j_actbio_2023_04_020
crossref_primary_10_1038_s41440_024_01938_7
crossref_primary_10_3390_medicina59030598
crossref_primary_10_3389_fphys_2021_651246
crossref_primary_10_1038_s41598_025_90332_5
crossref_primary_10_3389_fcvm_2025_1497292
crossref_primary_10_1093_ajh_hpaf141
crossref_primary_10_1111_cbdd_14628
crossref_primary_10_3389_fphar_2021_630385
crossref_primary_10_1002_clc_23881
crossref_primary_10_3390_jcm13185383
crossref_primary_10_15829_1728_8800_2025_4161
crossref_primary_10_3390_nu15133066
crossref_primary_10_1186_s12872_023_03509_z
Cites_doi 10.1007/s00392-016-0964-2
10.1097/HJH.0000000000001772
10.1161/JAHA.117.007564
10.1056/NEJMoa1611925
10.1161/hc3601.095927
10.1111/jch.13486
10.1016/j.jash.2018.06.010
10.1038/nrcardio.2016.45
10.1016/j.jcmg.2009.10.012
10.1253/circj.CJ-11-1256
10.1001/jama.288.23.2981
10.1161/JAHA.116.004823
10.1152/physrev.1999.79.1.215
10.1081/JCMR-200060631
10.1161/01.CIR.90.4.1786
10.1097/HJH.0000000000000416
10.1161/HYPERTENSIONAHA.107.087890
10.1001/jamacardio.2017.2275
10.1161/01.CIR.88.3.993
10.1038/jhh.2011.104
10.1056/NEJMoa1712231
10.1161/01.CIR.95.6.1464
10.7863/jum.2011.30.1.71
10.1161/CIRCRESAHA.117.305349
10.1161/JAHA.118.009959
10.2214/AJR.04.1868
10.1093/eurheartj/ehn533
10.1016/j.amjcard.2004.08.012
10.1097/MD.0000000000012067
10.1016/j.cardfail.2008.06.006
10.1161/JAHA.119.011961
10.1038/sj.jhh.1001785
10.1111/jch.13386
10.1161/HYPERTENSIONAHA.110.157339
10.1016/j.echo.2015.05.002
10.1161/CIRCIMAGING.108.819938
10.1161/HYPERTENSIONAHA.109.136655
10.1016/j.jcmg.2010.10.008
10.1016/j.amjcard.2018.10.006
10.1093/ajh/3.10.735
10.1016/j.echo.2016.01.011
10.1056/NEJMoa1402670
10.1093/ehjci/jes026
10.1016/j.jacc.2008.08.064
10.1161/HYPERTENSIONAHA.109.142042
10.1016/j.echo.2014.05.010
10.1007/s00330-004-2387-0
10.1161/01.CIR.0000091405.00772.6E
10.1067/mhj.2002.124863
10.1161/CIRCRESAHA.116.303697
10.1016/j.amjcard.2007.02.063
10.1136/heartjnl-2012-302353
10.1681/ASN.2010111185
10.1097/HJH.0b013e3283480fe9
10.1016/S0140-6736(02)08089-3
10.1093/eurheartj/ehi666
10.1161/HYPERTENSIONAHA.118.12114
10.1161/HYPERTENSIONAHA.118.12187
10.1016/j.jacc.2008.09.014
10.1111/j.1540-8175.2011.01410.x
10.1161/HYPERTENSIONAHA.117.10289
10.1007/s00125-016-3956-x
10.1097/00004872-199107000-00003
10.1016/j.ijcard.2018.06.031
10.1007/BF03324544
10.1016/0735-1097(92)90385-Z
10.1093/eurheartj/ehv598
10.1016/j.jacc.2012.09.035
10.1097/HJH.0b013e3283531eaf
10.1093/eurheartj/ehx525
10.2337/dc13-3055
10.1093/ehjci/jew328
10.1093/ehjci/jex094
10.1016/j.pcad.2014.05.003
10.1016/j.amjcard.2014.07.015
10.1016/S0735-1097(02)01712-6
10.1056/NEJM199005313222203
10.1016/S0002-9343(03)00158-X
10.1016/j.jacc.2013.05.019
10.1093/ajh/hpt215
10.1016/j.jacc.2010.09.001
10.1161/JAHA.116.004847
10.1161/JAHA.116.004152
10.1016/j.ijcard.2017.12.086
10.1016/j.echo.2015.09.009
10.1016/j.amjcard.2011.05.037
10.1161/01.str.0000442009.06663.48
10.1291/hypres.30.535
10.1093/eurheartj/ehv529
10.1016/j.jacc.2012.09.066
10.1161/01.CIR.103.1.102
10.1161/hc3901.096700
10.2337/dc16-1312
10.1161/CIRCULATIONAHA.114.010676
10.1056/NEJM198602063140602
10.1016/j.jacbts.2018.11.010
10.1016/j.amjcard.2011.05.038
10.1016/j.jacc.2013.07.074
10.1001/jama.1991.03470020057032
10.1016/j.echo.2017.06.026
10.1161/HYPERTENSIONAHA.119.12684
10.1007/s13244-018-0655-9
10.1161/01.CIR.0000104566.10178.AF
10.1161/01.HYP.0000052830.02773.E4
10.1016/j.echo.2014.10.003
10.1016/j.amjcard.2005.10.030
10.1016/j.jacc.2003.11.064
10.1161/01.CIR.94.6.1304
10.1054/jelc.2001.23360
10.1038/hr.2016.191
10.1161/01.HYP.0000223330.03088.58
10.1016/j.jcmg.2015.08.007
10.1093/eurheartj/ehy339
10.1056/NEJMoa1504720
10.1007/s11604-013-0238-0
10.1161/JAHA.113.000144
10.1161/JAHA.119.012272
10.1097/HJH.0000000000001691
10.1038/nrcardio.2011.154
10.1161/HYPERTENSIONAHA.118.11125
10.1016/j.amjcard.2011.06.053
10.1001/jama.296.10.1242
10.1093/ajh/hpx067
10.1016/j.jcmg.2015.12.020
10.1161/01.CIR.0000144303.24894.1C
10.1186/s12872-017-0556-8
10.3109/10641963.2015.1047943
10.1016/j.ahj.2018.07.007
10.1186/s12872-017-0663-6
10.2337/dc12-2673
10.1016/j.ijcard.2019.03.059
10.1093/ajh/hpu231
10.1081/CEH-120025336
10.1097/00004872-200106000-00023
10.1016/j.echo.2010.07.010
10.1016/j.amjcard.2012.03.046
10.1161/CIRCULATIONAHA.117.028441
10.1016/j.jchf.2017.04.012
10.1186/1532-429X-14-13
10.1016/j.amjcard.2018.04.053
10.1016/j.ahj.2006.10.012
10.1001/jama.1994.03520010045030
10.1016/0735-1097(92)90617-V
10.1111/echo.14234
10.1056/NEJMoa1409077
10.1038/ajh.2009.253
10.1016/j.jacc.2012.10.012
ContentType Journal Article
Copyright 2019 Elsevier Inc.
Elsevier Inc.
Copyright © 2019 Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2019 Elsevier Inc.
– notice: Elsevier Inc.
– notice: Copyright © 2019 Elsevier Inc. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.pcad.2019.11.009
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1532-8643
1873-1740
EndPage 21
ExternalDocumentID 31759953
10_1016_j_pcad_2019_11_009
S0033062019301434
1_s2_0_S0033062019301434
Genre Journal Article
Review
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
3O-
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8P~
9JM
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQQT
AAQXK
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABFRF
ABJNI
ABLJU
ABMAC
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACLOT
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EFKBS
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEB
HMK
HMO
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
M29
M41
MO0
N4W
N9A
O-L
O9-
OAUVE
OA~
OL0
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSZ
T5K
UGJ
UNMZH
WUQ
X7M
Z5R
ZGI
ZXP
~G-
~HD
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
PKN
RIG
AAIAV
ABLVK
ABYKQ
AHPSJ
AJBFU
LCYCR
9DU
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c462t-18599b418744185693374f08d2fde87f12e0bf6bde96cb5c735c04003e58bac3
ISICitedReferencesCount 251
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000521520900004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0033-0620
1873-1740
IngestDate Fri Jul 11 14:05:32 EDT 2025
Thu Jan 02 22:58:26 EST 2025
Sat Nov 29 07:29:06 EST 2025
Tue Nov 18 22:48:42 EST 2025
Fri Feb 23 02:49:55 EST 2024
Tue Feb 25 20:10:20 EST 2025
Tue Oct 14 19:24:50 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords MESA
RCT
HTN
MRI
STE
RAAS
DM
LV
Remodeling
BP
CCBs
CACS
2D
ASE
CHIP
ESC
ARIC
cLVH
eLVH
ESH
Anti-hypertension therapy
MI
CKD
HOPE
LIFE
SBP
Hypertension
ACC
EF
ACE
AF
SGLT2
ALLHAT
CAD
ECG
Left ventricular geometry
RWT
CR
CVD
EACVI
3D
HCM
SCD
Left ventricular hypertrophy
AHA
ARBs
HF
LVH
Myocardial infarction
Randomized clinical trial
Angiotensin receptor blockers
European Society of Hypertension
Cardiovascular disease
Left ventricle/ventricular
Calcium channel blockers
Electrocardiography
Blood pressure
Renin-angiotensin-aldosterone system
Concentric left ventricular hypertrophy
Sodium-glucose cotransporter type2
Heart failure
Systolic blood pressure
American College of Cardiology
American Heart Association
Multiethnic Study of Atherosclerosis
Angiotensin converting enzyme
Losartan Intervention for Endpoint Reduction
Hypertrophic cardiomyopathy
American Society of Echocardiography
Ejection fraction
Atherosclerosis Risk in Communities
Heart Outcomes Prevention Evaluation
Eccentric left ventricular hypertrophy
European Association of Cardiovascular Imaging
Two-dimensional
Relative wall thickness
Chlorthalidone, indapamide, and potassium-sparing diuretic/hydrochlorothiazide
Coronary artery calcium scoring
Atrial fibrillation
Concentric remodeling
Diabetes mellitus
Speckle tracking echocardiography
Chronic kidney disease
Sudden cardiac death
Coronary artery disease
Hypertension or hypertensive
European Society of Cardiology
Magnetic resonance imaging
Three-dimensional
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack
Language English
License Copyright © 2019 Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c462t-18599b418744185693374f08d2fde87f12e0bf6bde96cb5c735c04003e58bac3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
PMID 31759953
PQID 2317961460
PQPubID 23479
PageCount 12
ParticipantIDs proquest_miscellaneous_2317961460
pubmed_primary_31759953
crossref_citationtrail_10_1016_j_pcad_2019_11_009
crossref_primary_10_1016_j_pcad_2019_11_009
elsevier_sciencedirect_doi_10_1016_j_pcad_2019_11_009
elsevier_clinicalkeyesjournals_1_s2_0_S0033062019301434
elsevier_clinicalkey_doi_10_1016_j_pcad_2019_11_009
PublicationCentury 2000
PublicationDate 2020-01-01
PublicationDateYYYYMMDD 2020-01-01
PublicationDate_xml – month: 01
  year: 2020
  text: 2020-01-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Progress in cardiovascular diseases
PublicationTitleAlternate Prog Cardiovasc Dis
PublicationYear 2020
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Olsen, Wachtell, Hermann (bb0240) 2002; 144
Tamborini, Piazzese, Lang (bb0160) 2017; 30
(bb0620) 2002; 288
Malmqvist, Kahan, Edner (bb0670) 2001; 19
Ganau, Devereux, Roman (bb0025) 1992; 19
Mondillo, Galderisi, Mele (bb0185) 2011; 30
González, Ravassa, López (bb0365) 2018; 72
Rapsomaniki, Timmis, George (bb0005) 2014; 383
Okin, Watchtell, Devereux (bb0600) 2006; 296
Fukuda, Watanabe, Daimon (bb0170) 2012; 76
Greenland, Alpert, Beller (bb0030) 2010; 56
Petersen, Selvanayagam, Francis (bb0245) 2005; 7
Chatterjee, Bavishi, Sardar (bb0520) 2014; 114
Milani, Lavie, Mehra, Ventura, Kurtz, Messerli (bb0420) 2006; 97
Prineas, Rautaharju, Grandits, Crow (bb0560) 2001; 34
Neal, Perkovic, Mahaffey (bb0700) 2017; 377
Schwartzkopff, Motz, Frenzel, Vogt, Knauer, Strauer (bb0370) 1993; 88
Muraru, Cucchini, Mihăilă (bb0175) 2014; 27
Takami, Shigematsu (bb0665) 2003; 25
Cuspidi, Sala, Negri, Mancia, Morganti (bb0450) 2012; 26
Wang, Zhou, Lu, Chen, Xu, Li (bb0645) 2019; 8
Levy, Garrison, Savage (bb0385) 1990; 322
Aro, Reinier, Phan (bb0425) 2017; 19
Verdecchia, Angeli, Cavallini (bb0430) 2019; 73
Bluemke, Kronmal, Lima (bb0535) 2008; 52
EUGenMed Cardiovascular Clinical Study Group, Regitz-Zagrosek, Oertelt-Prigione (bb0400) 2016; 37
Kähönen-Väre, Brunni-Hakala, Lindroos, Pitkala, Strandberg, Tilvis (bb0540) 2004; 16
Schmieder, Wagner, Mayr (bb0640) 2017; 38
Levy, Salomon, D’Agostino, Belanger, Kannel (bb0555) 1994; 90
Smiseth, Torp, Opdahl, Haugaa, Urheim (bb0190) 2016; 37
Phelan, Collier, Thavendiranathan (bb0220) 2012; 98
Kao, Ang, Gandy (bb0735) 2011; 22
Cuspidi, Rescaldani, Tadic, Sala, Grassi (bb0590) 2014; 27
Bautista, Vera, Arenas, Gamarra (bb0360) 2005; 19
Konstam, Kramer, Patel, Maron, Udelson (bb0755) 2011; 4
Williams, Mancia, WS (bb0060) 2018; 39
Rosenstock, Jelaska, Frappin (bb0690) 2014; 37
Iwashima, Horio, Kamide (bb0315) 2010; 23
Alfakih, Reid, Jones, Sivananthan (bb0235) 2004; 14
Nagueh, Smiseth, Appleton (bb0455) 2016; 29
Rudolph, Abdel-Aty, Bohl (bb0265) 2009; 53
Cuspidi, Sala, Tadic, Gherbesi, Grassi, Mancia (bb0280) 2018; 270
Einhorn, Davis, Massie (bb0625) 2007; 153
Banegas, Ruilope, de la Sierra (bb0295) 2018; 378
Roush, Abdelfattah, Song, Ernst, Sica, Kostis (bb0675) 2018; 20
Verma, Garg, Yan (bb0050) 2016; 39
Linde, Gerdts, Waje-Andreassen (bb0530) 2018; 36
Norby, Chen, Soliman, Gottesman, Mosley, Alonso (bb0545) 2018; 204
Imbalzano, Zito, Carerj (bb0195) 2011; 28
Sattar, McLaren, Kristensen, Preiss, McMurray (bb0710) 2016; 59
Neeland, Drazner, Berry (bb0475) 2013; 61
Abdalla, Caughey, Tanner (bb0330) 2017; 6
McMurray, Packer, Desai (bb0635) 2014; 371
Galderisi, Lomoriello, Santoro (bb0215) 2010; 23
Maron (bb0260) 2012; 14
Soliman, Ambrosius, Cushman (bb0565) 2017; 136
SPRINT (bb0010) 2016; 36
Johnson, Oparil, Davis, Tereshchenko (bb0630) 2019; 8
Thavendiranathan, Grant, Negishi, Plana, Popović, Marwick (bb0140) 2013; 61
Mizukoshi, Takeuchi, Nagata (bb0180) 2016; 29
Bang, Soliman, Simpson (bb0075) 2017; 30
Jiang, Quan, Yang, Zhou, Hu, Zhang (bb0065) 2019; 21
McLenachan, Dargie (bb0375) 1990; 3
Rodriguez, Lin, Sacco (bb0395) 2006; 48
Gerdts, Izzo, Mancusi (bb0415) 2018; 258
Mancia, Zanchetti, Agabiti-Rosei (bb0320) 1997; 95
Whelton, Carey, Aronow (bb0020) 2018; 12
Mavrogeni, Katsi, Vartela (bb0225) 2017; 17
Blake, Rifai, Buring, Ridker (bb0355) 2003; 108
Cuspidi, Rescaldani, Tadic, Sala, Grassi, Mancia (bb0305) 2015; 33
Bushnell, McCullough, Awad (bb0410) 2014; 45
Bikkina, Levy, Evans (bb0525) 1994; 272
Shimada, Shiota (bb0145) 2012; 110
Cuspidi, Sala, Tadic, Rescaldani, Grassi, Mancia (bb0300) 2015; 28
Lauer, Anderson, Kannel, Levy (bb0115) 1991; 266
Yancy, Jessup, Bozkurt (bb0435) 2013; 62
Macmahon, Wilcken, GM (bb0585) 1986; 314
Takeda, Amano, Tachi, Tani, Mizuno, Kumita (bb0255) 2013; 31
Tsang, Salgo, Medvedofsky (bb0150) 2016; 9
Fagard, Celis, Thijs, Wouters (bb0570) 2009; 54
Cheng, Fernandes, Bluemke, McClelland, Kronmal, Lima (bb0105) 2009; 2
Park, Shin, Lee (bb0495) 2015; 37
ADVANCE Echocardiography Substudy Investigators (bb0615) 2011; 29
McMaster, Kirabo, Madhur, Harrison (bb0350) 2015; 116
Verdecchia, Reboldi, Gattobigio (bb0505) 2003; 41
De Marvao, Dawes, Shi (bb0445) 2015; 8
Brown, Lang, McCrimmon, Struthers (bb0705) 2017; 17
Connelly, Zhang, Visram (bb0055) 2019; 4
Devereux, Kjeldsen, Julius (bb0045) 2002; 359
Volpato, Mor-Avi, Narang (bb0165) 2019; 36
Galderisi, Esposito, Schiano-Lomoriello (bb0200) 2012; 13
Drazner, Rame, Marino (bb0460) 2004; 43
Krishnamoorthy, Brown, Ayers (bb0470) 2011; 108
Lang, Badano, Victor (bb0085) 2015; 28
Nunez, Arnett, Benjamin, Oakes, Liebson, Skelton (bb0390) 2004; 94
Packer, Anker, Butler, Filippatos, Zannad (bb0715) 2017; 2
Jacobs, Salgo, Goonewardena (bb0135) 2006; 27
Nagano, Higaki, Mikami (bb0655) 1991; 9
Szwejkowski, Gandy, Rekhraj (bb0740) 2013; 62
Rekhraj, Gandy, Szwejkowski (bb0730) 2013; 61
Palmieri, Bella, Arnett (bb0310) 2001; 103
Moazzami, Ostovaneh, Ambale Venkatesh (bb0550) 2018; 71
Cuspidi, Facchetti, Bombelli (bb0290) 2019; 73
Schmieder, Langenfeld, Friedrich, Schobel, Gatzka, Weihprecht (bb0660) 1996; 94
Marwick, Gillebert, Aurigemma (bb0130) 2015; 28
Mehta, Rame, Khera (bb0480) 2007; 49
De Simone, Devereux, Izzo (bb0575) 2013; 2
Häring, Merker, Seewaldt-Becker (bb0685) 2013; 36
Cuspidi, Sala, Negri, Mancia, Morganti (bb0270) 2012; 26
Messerli, Rimoldi, Bangalore (bb0440) 2017; 5
Okin, Hille, Kjeldsen, Devereux (bb0080) 2017; 6
Turkbey, McClelland, Kronmal (bb0110) 2010; 3
Zinman, Wanner, Lachin (bb0695) 2015; 373
Méndez, Soler, Rodríguez, Barriales, Ochoa, Monserrat (bb0250) 2018; 9
Salton, Chuang, O’Donnell (bb0100) 2002; 39
Medvedofsky, Mor-Avi, Amzulescu (bb0155) 2018; 19
Kamo, Akazawa, Komuro (bb0345) 2015; 117
Xu, Hu, Lu (bb0720) 2008; 14
Jung, Park, Oh (bb0285) 2017; 40
Kansal, Lester, Surapaneni (bb0210) 2011; 108
Nepper-Christensen, Lønborg, Ahtarovski (bb0500) 2017; 6
Cao, Broughton, Waits, Nguyen, Li, Soliman (bb0275) 2019; 123
Lønnebakken, Izzo, Mancusi (bb0580) 2017; 6
Bhatt, Kandzari, O’Neill (bb0745) 2014; 370
Natori, Lai, Finn (bb0095) 2006; 186
Ko, Rahman, Schnabel, Yin, Benjamin, Christophersen (bb0405) 2016; 13
Roush, Abdelfattah, Song, Kostis, Ernst, Sica (bb0680) 2018; 36
Lu, Wang, Liu, Wang, Zhang, Shan (bb0750) 2016; 105
Gjesdal, Bluemke, Lima (bb0090) 2011; 8
Chirinos, Segers (bb0120) 2010; 56
Swynghedauw (bb0340) 1999; 79
Milani, Drazner, Lavie, Morin, Ventura (bb0465) 2011; 108
Perrone-filardi, Coca, Galderisi (bb0230) 2017; 18
Sparapani, Dabbouseh, Gutterman (bb0070) 2019; 8
Eskerud, Gerdts, Larsen, Lønnebakken (bb0485) 2019; 286
de Simone, Daniels, Devereux (bb0125) 1992; 20
Pitt, Reichek, Willenbrock (bb0610) 2003; 108
Levick, Murray, Janicki, Brower (bb0380) 2010; 55
Egan, Li, Hutchison, Ferdinand (bb0015) 2014; 130
Erküner, Dudink, Nieuwlaat (bb0510) 2018; 122
Klingbeil, Schneider, Martus, Messerli, Schmieder (bb0650) 2003; 115
Engberding, Spiekermann, Schaefer (bb0725) 2004; 110
Bliziotis, Destounis, Stergiou (bb0325) 2012; 30
Lavie, Patel, Milani, Ventura, Shah, Gilliland (bb0035) 2014; 57
Mathew, Sleight, Lonn (bb0040) 2001; 104
Richand, Lafitte, Reant (bb0205) 2007; 100
Devereux, Palmieri, Sharpe (bb0605) 2007; 104
Palatini, Visentin, Dorigatti (bb0595) 2009; 30
Salvetti, Paini, Aggiusti (bb0335) 2019; 73
Hennersdorf, Schueller, Steiner, Strauer (bb0515) 2007; 30
Kim, Her, Choi (bb0490) 2018; 97
Mavrogeni (10.1016/j.pcad.2019.11.009_bb0225) 2017; 17
Takami (10.1016/j.pcad.2019.11.009_bb0665) 2003; 25
Smiseth (10.1016/j.pcad.2019.11.009_bb0190) 2016; 37
Bliziotis (10.1016/j.pcad.2019.11.009_bb0325) 2012; 30
Rekhraj (10.1016/j.pcad.2019.11.009_bb0730) 2013; 61
Verdecchia (10.1016/j.pcad.2019.11.009_bb0430) 2019; 73
Jiang (10.1016/j.pcad.2019.11.009_bb0065) 2019; 21
Fukuda (10.1016/j.pcad.2019.11.009_bb0170) 2012; 76
Shimada (10.1016/j.pcad.2019.11.009_bb0145) 2012; 110
Kansal (10.1016/j.pcad.2019.11.009_bb0210) 2011; 108
Abdalla (10.1016/j.pcad.2019.11.009_bb0330) 2017; 6
Yancy (10.1016/j.pcad.2019.11.009_bb0435) 2013; 62
EUGenMed Cardiovascular Clinical Study Group (10.1016/j.pcad.2019.11.009_bb0400) 2016; 37
Connelly (10.1016/j.pcad.2019.11.009_bb0055) 2019; 4
Malmqvist (10.1016/j.pcad.2019.11.009_bb0670) 2001; 19
Gerdts (10.1016/j.pcad.2019.11.009_bb0415) 2018; 258
Xu (10.1016/j.pcad.2019.11.009_bb0720) 2008; 14
Bautista (10.1016/j.pcad.2019.11.009_bb0360) 2005; 19
Milani (10.1016/j.pcad.2019.11.009_bb0465) 2011; 108
Soliman (10.1016/j.pcad.2019.11.009_bb0565) 2017; 136
McMurray (10.1016/j.pcad.2019.11.009_bb0635) 2014; 371
Neeland (10.1016/j.pcad.2019.11.009_bb0475) 2013; 61
Jung (10.1016/j.pcad.2019.11.009_bb0285) 2017; 40
Méndez (10.1016/j.pcad.2019.11.009_bb0250) 2018; 9
Chatterjee (10.1016/j.pcad.2019.11.009_bb0520) 2014; 114
Pitt (10.1016/j.pcad.2019.11.009_bb0610) 2003; 108
Levy (10.1016/j.pcad.2019.11.009_bb0555) 1994; 90
Lang (10.1016/j.pcad.2019.11.009_bb0085) 2015; 28
Prineas (10.1016/j.pcad.2019.11.009_bb0560) 2001; 34
Cuspidi (10.1016/j.pcad.2019.11.009_bb0300) 2015; 28
Aro (10.1016/j.pcad.2019.11.009_bb0425) 2017; 19
de Simone (10.1016/j.pcad.2019.11.009_bb0125) 1992; 20
Kao (10.1016/j.pcad.2019.11.009_bb0735) 2011; 22
Mizukoshi (10.1016/j.pcad.2019.11.009_bb0180) 2016; 29
Mehta (10.1016/j.pcad.2019.11.009_bb0480) 2007; 49
Fagard (10.1016/j.pcad.2019.11.009_bb0570) 2009; 54
Krishnamoorthy (10.1016/j.pcad.2019.11.009_bb0470) 2011; 108
Marwick (10.1016/j.pcad.2019.11.009_bb0130) 2015; 28
Macmahon (10.1016/j.pcad.2019.11.009_bb0585) 1986; 314
ADVANCE Echocardiography Substudy Investigators (10.1016/j.pcad.2019.11.009_bb0615) 2011; 29
Nagueh (10.1016/j.pcad.2019.11.009_bb0455) 2016; 29
Mancia (10.1016/j.pcad.2019.11.009_bb0320) 1997; 95
Lu (10.1016/j.pcad.2019.11.009_bb0750) 2016; 105
(10.1016/j.pcad.2019.11.009_bb0620) 2002; 288
Chirinos (10.1016/j.pcad.2019.11.009_bb0120) 2010; 56
Iwashima (10.1016/j.pcad.2019.11.009_bb0315) 2010; 23
Lønnebakken (10.1016/j.pcad.2019.11.009_bb0580) 2017; 6
Häring (10.1016/j.pcad.2019.11.009_bb0685) 2013; 36
Cuspidi (10.1016/j.pcad.2019.11.009_bb0450) 2012; 26
McLenachan (10.1016/j.pcad.2019.11.009_bb0375) 1990; 3
Moazzami (10.1016/j.pcad.2019.11.009_bb0550) 2018; 71
Palatini (10.1016/j.pcad.2019.11.009_bb0595) 2009; 30
Kamo (10.1016/j.pcad.2019.11.009_bb0345) 2015; 117
Schmieder (10.1016/j.pcad.2019.11.009_bb0640) 2017; 38
Blake (10.1016/j.pcad.2019.11.009_bb0355) 2003; 108
Alfakih (10.1016/j.pcad.2019.11.009_bb0235) 2004; 14
Palmieri (10.1016/j.pcad.2019.11.009_bb0310) 2001; 103
Natori (10.1016/j.pcad.2019.11.009_bb0095) 2006; 186
Volpato (10.1016/j.pcad.2019.11.009_bb0165) 2019; 36
Hennersdorf (10.1016/j.pcad.2019.11.009_bb0515) 2007; 30
Packer (10.1016/j.pcad.2019.11.009_bb0715) 2017; 2
Medvedofsky (10.1016/j.pcad.2019.11.009_bb0155) 2018; 19
De Simone (10.1016/j.pcad.2019.11.009_bb0575) 2013; 2
Whelton (10.1016/j.pcad.2019.11.009_bb0020) 2018; 12
Cuspidi (10.1016/j.pcad.2019.11.009_bb0270) 2012; 26
Maron (10.1016/j.pcad.2019.11.009_bb0260) 2012; 14
Cao (10.1016/j.pcad.2019.11.009_bb0275) 2019; 123
Levy (10.1016/j.pcad.2019.11.009_bb0385) 1990; 322
Verma (10.1016/j.pcad.2019.11.009_bb0050) 2016; 39
Milani (10.1016/j.pcad.2019.11.009_bb0420) 2006; 97
Ganau (10.1016/j.pcad.2019.11.009_bb0025) 1992; 19
Norby (10.1016/j.pcad.2019.11.009_bb0545) 2018; 204
Sparapani (10.1016/j.pcad.2019.11.009_bb0070) 2019; 8
Nagano (10.1016/j.pcad.2019.11.009_bb0655) 1991; 9
Sattar (10.1016/j.pcad.2019.11.009_bb0710) 2016; 59
Salton (10.1016/j.pcad.2019.11.009_bb0100) 2002; 39
Galderisi (10.1016/j.pcad.2019.11.009_bb0200) 2012; 13
Szwejkowski (10.1016/j.pcad.2019.11.009_bb0740) 2013; 62
Mathew (10.1016/j.pcad.2019.11.009_bb0040) 2001; 104
Kim (10.1016/j.pcad.2019.11.009_bb0490) 2018; 97
Okin (10.1016/j.pcad.2019.11.009_bb0600) 2006; 296
Greenland (10.1016/j.pcad.2019.11.009_bb0030) 2010; 56
Neal (10.1016/j.pcad.2019.11.009_bb0700) 2017; 377
Brown (10.1016/j.pcad.2019.11.009_bb0705) 2017; 17
Thavendiranathan (10.1016/j.pcad.2019.11.009_bb0140) 2013; 61
Rapsomaniki (10.1016/j.pcad.2019.11.009_bb0005) 2014; 383
Bushnell (10.1016/j.pcad.2019.11.009_bb0410) 2014; 45
Klingbeil (10.1016/j.pcad.2019.11.009_bb0650) 2003; 115
Imbalzano (10.1016/j.pcad.2019.11.009_bb0195) 2011; 28
Jacobs (10.1016/j.pcad.2019.11.009_bb0135) 2006; 27
Eskerud (10.1016/j.pcad.2019.11.009_bb0485) 2019; 286
Rudolph (10.1016/j.pcad.2019.11.009_bb0265) 2009; 53
Turkbey (10.1016/j.pcad.2019.11.009_bb0110) 2010; 3
Konstam (10.1016/j.pcad.2019.11.009_bb0755) 2011; 4
Engberding (10.1016/j.pcad.2019.11.009_bb0725) 2004; 110
Tamborini (10.1016/j.pcad.2019.11.009_bb0160) 2017; 30
Verdecchia (10.1016/j.pcad.2019.11.009_bb0505) 2003; 41
Cuspidi (10.1016/j.pcad.2019.11.009_bb0590) 2014; 27
Zinman (10.1016/j.pcad.2019.11.009_bb0695) 2015; 373
Takeda (10.1016/j.pcad.2019.11.009_bb0255) 2013; 31
Levick (10.1016/j.pcad.2019.11.009_bb0380) 2010; 55
Tsang (10.1016/j.pcad.2019.11.009_bb0150) 2016; 9
De Marvao (10.1016/j.pcad.2019.11.009_bb0445) 2015; 8
Perrone-filardi (10.1016/j.pcad.2019.11.009_bb0230) 2017; 18
Egan (10.1016/j.pcad.2019.11.009_bb0015) 2014; 130
Devereux (10.1016/j.pcad.2019.11.009_bb0605) 2007; 104
Williams (10.1016/j.pcad.2019.11.009_bb0060) 2018; 39
Galderisi (10.1016/j.pcad.2019.11.009_bb0215) 2010; 23
Cuspidi (10.1016/j.pcad.2019.11.009_bb0280) 2018; 270
Einhorn (10.1016/j.pcad.2019.11.009_bb0625) 2007; 153
Cheng (10.1016/j.pcad.2019.11.009_bb0105) 2009; 2
Nunez (10.1016/j.pcad.2019.11.009_bb0390) 2004; 94
Nepper-Christensen (10.1016/j.pcad.2019.11.009_bb0500) 2017; 6
Roush (10.1016/j.pcad.2019.11.009_bb0680) 2018; 36
Devereux (10.1016/j.pcad.2019.11.009_bb0045) 2002; 359
Richand (10.1016/j.pcad.2019.11.009_bb0205) 2007; 100
Cuspidi (10.1016/j.pcad.2019.11.009_bb0305) 2015; 33
Lavie (10.1016/j.pcad.2019.11.009_bb0035) 2014; 57
Salvetti (10.1016/j.pcad.2019.11.009_bb0335) 2019; 73
Schmieder (10.1016/j.pcad.2019.11.009_bb0660) 1996; 94
Lauer (10.1016/j.pcad.2019.11.009_bb0115) 1991; 266
Roush (10.1016/j.pcad.2019.11.009_bb0675) 2018; 20
Rosenstock (10.1016/j.pcad.2019.11.009_bb0690) 2014; 37
Schwartzkopff (10.1016/j.pcad.2019.11.009_bb0370) 1993; 88
Cuspidi (10.1016/j.pcad.2019.11.009_bb0290) 2019; 73
Bikkina (10.1016/j.pcad.2019.11.009_bb0525) 1994; 272
Phelan (10.1016/j.pcad.2019.11.009_bb0220) 2012; 98
Rodriguez (10.1016/j.pcad.2019.11.009_bb0395) 2006; 48
Messerli (10.1016/j.pcad.2019.11.009_bb0440) 2017; 5
Swynghedauw (10.1016/j.pcad.2019.11.009_bb0340) 1999; 79
Banegas (10.1016/j.pcad.2019.11.009_bb0295) 2018; 378
Johnson (10.1016/j.pcad.2019.11.009_bb0630) 2019; 8
SPRINT (10.1016/j.pcad.2019.11.009_bb0010) 2016; 36
Drazner (10.1016/j.pcad.2019.11.009_bb0460) 2004; 43
Mondillo (10.1016/j.pcad.2019.11.009_bb0185) 2011; 30
Kähönen-Väre (10.1016/j.pcad.2019.11.009_bb0540) 2004; 16
Petersen (10.1016/j.pcad.2019.11.009_bb0245) 2005; 7
Wang (10.1016/j.pcad.2019.11.009_bb0645) 2019; 8
Okin (10.1016/j.pcad.2019.11.009_bb0080) 2017; 6
Gjesdal (10.1016/j.pcad.2019.11.009_bb0090) 2011; 8
McMaster (10.1016/j.pcad.2019.11.009_bb0350) 2015; 116
Ko (10.1016/j.pcad.2019.11.009_bb0405) 2016; 13
Park (10.1016/j.pcad.2019.11.009_bb0495) 2015; 37
Erküner (10.1016/j.pcad.2019.11.009_bb0510) 2018; 122
Olsen (10.1016/j.pcad.2019.11.009_bb0240) 2002; 144
González (10.1016/j.pcad.2019.11.009_bb0365) 2018; 72
Bang (10.1016/j.pcad.2019.11.009_bb0075) 2017; 30
Muraru (10.1016/j.pcad.2019.11.009_bb0175) 2014; 27
Bluemke (10.1016/j.pcad.2019.11.009_bb0535) 2008; 52
Bhatt (10.1016/j.pcad.2019.11.009_bb0745) 2014; 370
Linde (10.1016/j.pcad.2019.11.009_bb0530) 2018; 36
References_xml – volume: 19
  start-page: 149
  year: 2005
  end-page: 154
  ident: bb0360
  article-title: Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-α) and essential hypertension
  publication-title: J Hum Hypertens
– volume: 41
  start-page: 218
  year: 2003
  end-page: 223
  ident: bb0505
  article-title: Atrial fibrillation in hypertension: predictors and outcome
  publication-title: Hypertension.
– volume: 322
  start-page: 1561
  year: 1990
  end-page: 1566
  ident: bb0385
  article-title: DS. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study
  publication-title: N Engl J Med
– volume: 13
  start-page: 730
  year: 2012
  end-page: 738
  ident: bb0200
  article-title: Correlates of global area strain in native hypertensive patients: a three-dimensional speckle-tracking echocardiography study
  publication-title: Eur Heart J Cardiovasc Imaging
– volume: 27
  start-page: 146
  year: 2014
  end-page: 156
  ident: bb0590
  article-title: Effects of bariatric surgery on cardiac structure and function: a systematic review and meta-analysis
  publication-title: Am J Hypertens
– volume: 62
  start-page: e147
  year: 2013
  end-page: e239
  ident: bb0435
  article-title: 2013 ACCF/AHA guideline for the management of heart failure
  publication-title: J Am Coll Cardiol
– volume: 103
  start-page: 102
  year: 2001
  end-page: 107
  ident: bb0310
  article-title: Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: hypertension genetic epidemiology network (HyperGEN) study
  publication-title: Circulation.
– volume: 59
  start-page: 1333
  year: 2016
  end-page: 1339
  ident: bb0710
  article-title: SGLT2 inhibition and cardiovascular events: why did EMPA-REG outcomes surprise and what were the likely mechanisms?
  publication-title: Diabetologia.
– volume: 8
  year: 2019
  ident: bb0645
  article-title: Effects of the angiotensin-receptor neprilysin inhibitor on cardiac reverse remodeling: meta-analysis
  publication-title: J Am Heart Assoc
– volume: 26
  start-page: 343
  year: 2012
  end-page: 349
  ident: bb0270
  article-title: Italian Society of Hypertension. Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies
  publication-title: J Hum Hypertens
– volume: 73
  start-page: 736
  year: 2019
  end-page: 742
  ident: bb0335
  article-title: Unattended versus attended blood pressure measurement
  publication-title: Hypertension.
– volume: 73
  start-page: 1071
  year: 2019
  end-page: 1078
  ident: bb0430
  article-title: Sudden cardiac death in hypertensive patients
  publication-title: Hypertension.
– volume: 286
  start-page: 1
  year: 2019
  end-page: 6
  ident: bb0485
  article-title: Left ventricular hypertrophy contributes to myocardial ischemia in non-obstructive coronary artery disease (the MicroCAD study)
  publication-title: Int J Cardiol
– volume: 45
  start-page: 1545
  year: 2014
  end-page: 1588
  ident: bb0410
  article-title: Guidelines for the prevention of stroke in women
  publication-title: Stroke
– volume: 370
  start-page: 1393
  year: 2014
  end-page: 1401
  ident: bb0745
  article-title: A controlled trial of renal denervation for resistant hypertension
  publication-title: N Engl J Med
– volume: 114
  start-page: 1049
  year: 2014
  end-page: 1052
  ident: bb0520
  article-title: Meta-analysis of left ventricular hypertrophy and sustained arrhythmias
  publication-title: Am J Cardiol
– volume: 378
  start-page: 1509
  year: 2018
  end-page: 1520
  ident: bb0295
  article-title: Relationship between clinic and ambulatory blood-pressure measurements and mortality
  publication-title: N Engl J Med
– volume: 49
  start-page: 1385
  year: 2007
  end-page: 1391
  ident: bb0480
  article-title: Left ventricular hypertrophy, subclinical atherosclerosis, and inflammation
  publication-title: Hypertension
– volume: 123
  start-page: 274
  year: 2019
  end-page: 283
  ident: bb0275
  article-title: Interrelations between hypertension and electrocardiographic left ventricular hypertrophy and their associations with cardiovascular mortality
  publication-title: Am J Cardiol
– volume: 38
  start-page: 3308
  year: 2017
  end-page: 3317
  ident: bb0640
  article-title: The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study
  publication-title: Eur Heart J
– volume: 19
  start-page: 1146
  year: 2017
  end-page: 1152
  ident: bb0425
  article-title: Left-ventricular geometry and risk of sudden cardiac arrest in patients with preserved or moderately reduced left-ventricular ejection fraction
  publication-title: Europace.
– volume: 97
  start-page: 959
  year: 2006
  end-page: 963
  ident: bb0420
  article-title: Left ventricular geometry and survival in patients with normal left ventricular ejection fraction
  publication-title: Am J Cardiol
– volume: 108
  start-page: 1831
  year: 2003
  end-page: 1838
  ident: bb0610
  article-title: Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study
  publication-title: Circulation.
– volume: 288
  start-page: 2981
  year: 2002
  end-page: 2997
  ident: bb0620
  article-title: The antihypertensive and lipid-lowering treatment to prevent heart attack trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
  publication-title: JAMA.
– volume: 8
  start-page: 1
  year: 2019
  end-page: 15
  ident: bb0630
  article-title: Prevention of heart failure in hypertension—disentangling the role of evolving left ventricular hypertrophy and blood pressure lowering: the ALLHAT study
  publication-title: J Am Heart Assoc
– volume: 95
  start-page: 1464
  year: 1997
  end-page: 1470
  ident: bb0320
  article-title: Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE study group. Study on ambulatory monitoring of blood pressure and Lisinopril evaluation
  publication-title: Circulation.
– volume: 371
  start-page: 993
  year: 2014
  end-page: 1004
  ident: bb0635
  article-title: Angiotensin–Neprilysin inhibition versus Enalapril in heart failure
  publication-title: N Engl J Med
– volume: 23
  start-page: 290
  year: 2010
  end-page: 298
  ident: bb0315
  article-title: Additive interaction of metabolic syndrome and chronic kidney disease on cardiac hypertrophy, and risk of cardiovascular disease in hypertension
  publication-title: Am J Hypertens
– volume: 17
  start-page: 132
  year: 2017
  ident: bb0225
  article-title: The emerging role of cardiovascular magnetic resonance in the evaluation of hypertensive heart disease
  publication-title: BMC Cardiovasc Disord
– volume: 39
  start-page: e212
  year: 2016
  end-page: e213
  ident: bb0050
  article-title: Effect of Empagliflozin on left ventricular mass and diastolic function in individuals with diabetes: an important clue to the EMPA-REG OUTCOME trial?
  publication-title: Diabetes Care
– volume: 36
  start-page: 3396
  year: 2013
  end-page: 3404
  ident: bb0685
  article-title: Empagliflozin as add-on to metformin plus sulfonylurea in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial
  publication-title: Diabetes Care
– volume: 71
  start-page: 429
  year: 2018
  end-page: 436
  ident: bb0550
  article-title: Left ventricular hypertrophy and remodeling and risk of cognitive impairment and dementia: MESA (multi-ethnic study of atherosclerosis)
  publication-title: Hypertension.
– volume: 8
  start-page: 673
  year: 2011
  end-page: 685
  ident: bb0090
  article-title: Cardiac remodeling at the population level—risk factors, screening, and outcomes
  publication-title: Nat Rev Cardiol
– volume: 43
  start-page: 2207
  year: 2004
  end-page: 2215
  ident: bb0460
  article-title: Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the cardiovascular health study
  publication-title: J Am Coll Cardiol
– volume: 61
  start-page: 187
  year: 2013
  end-page: 195
  ident: bb0475
  article-title: Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population
  publication-title: J Am Coll Cardiol
– volume: 30
  start-page: 1289
  year: 2012
  end-page: 1299
  ident: bb0325
  article-title: Home versus ambulatory and office blood pressure in predicting target organ damage in hypertension: a systematic review and meta-analysis
  publication-title: J Hypertens
– volume: 48
  start-page: 87
  year: 2006
  end-page: 92
  ident: bb0395
  article-title: Prognostic implications of left ventricular mass among Hispanics
  publication-title: Hypertension
– volume: 4
  start-page: 98
  year: 2011
  end-page: 108
  ident: bb0755
  article-title: Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment
  publication-title: JACC Cardiovasc Imaging
– volume: 2
  start-page: 191
  year: 2009
  end-page: 198
  ident: bb0105
  article-title: Age-related left ventricular remodeling and associated risk for cardiovascular outcomes
  publication-title: Circ Cardiovasc Imaging
– volume: 6
  year: 2017
  ident: bb0500
  article-title: Left ventricular hypertrophy is associated with increased infarct size and decreased myocardial salvage in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
  publication-title: J Am Heart Assoc
– volume: 9
  start-page: 769
  year: 2016
  end-page: 782
  ident: bb0150
  article-title: Transthoracic 3D echocardiographic left heart chamber quantification using an automated adaptive analytics algorithm
  publication-title: JACC Cardiovasc Imaging
– volume: 28
  start-page: 1
  year: 2015
  end-page: 39.e14
  ident: bb0085
  article-title: Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
  publication-title: J Am Soc Echocardiogr
– volume: 258
  start-page: 257
  year: 2018
  end-page: 261
  ident: bb0415
  article-title: Left ventricular hypertrophy offsets the sex difference in cardiovascular risk (the Campania salute network)
  publication-title: Int J Cardiol
– volume: 27
  start-page: 460
  year: 2006
  end-page: 468
  ident: bb0135
  article-title: Rapid online quantification of left ventricular volume from real-time three-dimensional echocardiographic data
  publication-title: Eur Heart J
– volume: 56
  start-page: e50
  year: 2010
  end-page: e103
  ident: bb0030
  article-title: 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults
  publication-title: J Am Coll Cardiol
– volume: 153
  start-page: 42
  year: 2007
  end-page: 53
  ident: bb0625
  article-title: The antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT) heart failure validation study: diagnosis and prognosis
  publication-title: Am Heart J
– volume: 52
  start-page: 2148
  year: 2008
  end-page: 2155
  ident: bb0535
  article-title: The relationship of left ventricular mass and geometry to incident cardiovascular events
  publication-title: J Am Coll Cardiol
– volume: 116
  start-page: 1022
  year: 2015
  end-page: 1033
  ident: bb0350
  article-title: Inflammation, immunity, and hypertensive end-organ damage
  publication-title: Circ Res
– volume: 2
  start-page: 1
  year: 2013
  end-page: 8
  ident: bb0575
  article-title: Lack of reduction of left ventricular mass in treated hypertension: the strong heart study
  publication-title: J Am Heart Assoc
– volume: 204
  start-page: 58
  year: 2018
  end-page: 67
  ident: bb0545
  article-title: Association of left ventricular hypertrophy with cognitive decline and dementia risk over 20 years: the atherosclerosis risk in communities–neurocognitive study (ARIC-NCS)
  publication-title: Am Heart J
– volume: 62
  start-page: 2284
  year: 2013
  end-page: 2293
  ident: bb0740
  article-title: Allopurinol reduces left ventricular mass in patients with type 2 diabetes and left ventricular hypertrophy
  publication-title: J Am Coll Cardiol
– volume: 296
  start-page: 1242
  year: 2006
  end-page: 1248
  ident: bb0600
  article-title: Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension
  publication-title: JAMA
– volume: 359
  start-page: 995
  year: 2002
  end-page: 1003
  ident: bb0045
  article-title: Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
  publication-title: Lancet
– volume: 53
  start-page: 284
  year: 2009
  end-page: 291
  ident: bb0265
  article-title: Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy
  publication-title: J Am Coll Cardiol
– volume: 34
  start-page: 91
  year: 2001
  end-page: 101
  ident: bb0560
  article-title: Independent risk for cardiovascular disease predicted by modified continuous score electrocardiographic criteria for 6-year incidence and regression of left ventricular hypertrophy among clinically disease free men: 16-year follow-up for the multiple
  publication-title: J Electrocardiol
– volume: 76
  start-page: 1177
  year: 2012
  end-page: 1181
  ident: bb0170
  article-title: Normal values of real-time 3-dimensional echocardiographic parameters in a healthy Japanese population: the JAMP-3D study
  publication-title: Circ J
– volume: 30
  start-page: 535
  year: 2007
  end-page: 540
  ident: bb0515
  article-title: Prevalence of paroxysmal atrial fibrillation depending on the regression of left ventricular hypertrophy in arterial hypertension
  publication-title: Hypertens Res
– volume: 20
  start-page: 1251
  year: 1992
  end-page: 1260
  ident: bb0125
  article-title: Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight
  publication-title: J Am Coll Cardiol
– volume: 36
  start-page: 1247
  year: 2018
  end-page: 1255
  ident: bb0680
  article-title: Hydrochlorothiazide and alternative diuretics versus renin-angiotensin system inhibitors for the regression of left ventricular hypertrophy: a head-to-head meta-analysis
  publication-title: J Hypertens
– volume: 108
  start-page: 992
  year: 2011
  end-page: 996
  ident: bb0465
  article-title: Progression from concentric left ventricular hypertrophy and normal ejection fraction to left ventricular dysfunction
  publication-title: Am J Cardiol
– volume: 3
  start-page: 266
  year: 2010
  end-page: 274
  ident: bb0110
  article-title: The impact of obesity on the left ventricle
  publication-title: JACC Cardiovasc Imaging
– volume: 18
  start-page: 945
  year: 2017
  end-page: 960
  ident: bb0230
  article-title: Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients. A consensus paper from the European Association of Cardiovascular Imaging (EACVI), the European Society of Cardiology Council on Hypertension, and the European Society of Hypertension (ESH)
  publication-title: Eur Heart J Cardiovasc Imaging
– volume: 94
  start-page: 1304
  year: 1996
  end-page: 1309
  ident: bb0660
  article-title: Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension
  publication-title: Circulation
– volume: 30
  start-page: 71
  year: 2011
  end-page: 83
  ident: bb0185
  article-title: Speckle-tracking echocardiography: a new technique for assessing myocardial function
  publication-title: J Ultrasound Med
– volume: 29
  start-page: 1439
  year: 2011
  end-page: 1447
  ident: bb0615
  article-title: Effects of perindopril-indapamide on left ventricular diastolic function and mass in patients with type 2 diabetes: the ADVANCE Echocardiography Substudy
  publication-title: J Hypertens
– volume: 108
  start-page: 2993
  year: 2003
  end-page: 2999
  ident: bb0355
  article-title: Blood pressure, C-reactive protein, and risk of future cardiovascular events
  publication-title: Circulation.
– volume: 37
  start-page: 1815
  year: 2014
  end-page: 1823
  ident: bb0690
  article-title: Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with Empagliflozin added to titrated multiple daily injections of insulin in obese inadequately controlled type 2 diabetes
  publication-title: Diabetes Care
– volume: 29
  start-page: 277
  year: 2016
  end-page: 314
  ident: bb0455
  article-title: Recommendations for the evaluation of left ventricular diastolic function by Echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
  publication-title: J Am Soc Echocardiogr
– volume: 56
  start-page: 563
  year: 2010
  end-page: 570
  ident: bb0120
  article-title: Noninvasive evaluation of left ventricular afterload
  publication-title: Hypertension.
– volume: 28
  start-page: 806
  year: 2015
  end-page: 813
  ident: bb0300
  article-title: Untreated masked hypertension and subclinical cardiac damage: a systematic review and meta-analysis
  publication-title: Am J Hypertens
– volume: 17
  start-page: 229
  year: 2017
  ident: bb0705
  article-title: Does dapagliflozin regress left ventricular hypertrophy in patients with type 2 diabetes? A prospective, double-blind, randomised, placebo-controlled study
  publication-title: BMC Cardiovasc Disord
– volume: 105
  start-page: 648
  year: 2016
  end-page: 656
  ident: bb0750
  article-title: Reductions of left ventricular mass and atrial size following renal denervation: a meta-analysis
  publication-title: Clin Res Cardiol
– volume: 19
  start-page: 47
  year: 2018
  end-page: 58
  ident: bb0155
  article-title: Three-dimensional echocardiographic quantification of the left-heart chambers using an automated adaptive analytics algorithm: multicentre validation study
  publication-title: Eur Hear J - Cardiovasc Imaging
– volume: 16
  start-page: 147
  year: 2004
  end-page: 152
  ident: bb0540
  article-title: Left ventricular hypertrophy and blood pressure as predictors of cognitive decline in old age
  publication-title: Aging Clin Exp Res
– volume: 2
  start-page: 1025
  year: 2017
  ident: bb0715
  article-title: Effects of sodium-glucose Cotransporter 2 inhibitors for the treatment of patients with heart failure
  publication-title: JAMA Cardiol
– volume: 6
  year: 2017
  ident: bb0330
  article-title: Associations of blood pressure dipping patterns with left ventricular mass and left ventricular hypertrophy in blacks: the Jackson heart study
  publication-title: J Am Heart Assoc
– volume: 88
  start-page: 993
  year: 1993
  end-page: 1003
  ident: bb0370
  article-title: Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension
  publication-title: Circulation.
– volume: 36
  start-page: 140
  year: 2016
  end-page: 141
  ident: bb0010
  article-title: A randomized trial of intensive versus standard blood-pressure control
  publication-title: N Engl J Med
– volume: 28
  start-page: 649
  year: 2011
  end-page: 657
  ident: bb0195
  article-title: Left ventricular function in hypertension: new insight by speckle tracking echocardiography
  publication-title: Echocardiography
– volume: 108
  start-page: 1322
  year: 2011
  end-page: 1326
  ident: bb0210
  article-title: Usefulness of two-dimensional and speckle tracking Echocardiography in “gray zone” left ventricular hypertrophy to differentiate professional football player’s heart from hypertrophic cardiomyopathy
  publication-title: Am J Cardiol
– volume: 23
  start-page: 1190
  year: 2010
  end-page: 1198
  ident: bb0215
  article-title: Differences of myocardial systolic deformation and correlates of diastolic function in competitive rowers and young hypertensives: a speckle-tracking echocardiography study
  publication-title: J Am Soc Echocardiogr
– volume: 122
  start-page: 578
  year: 2018
  end-page: 583
  ident: bb0510
  article-title: Effect of systemic hypertension with versus without left ventricular hypertrophy on the progression of atrial fibrillation (from the Euro Heart Survey)
  publication-title: Am J Cardiol
– volume: 79
  start-page: 215
  year: 1999
  end-page: 262
  ident: bb0340
  article-title: Molecular mechanisms of myocardial remodeling
  publication-title: Physiol Rev
– volume: 14
  start-page: 1813
  year: 2004
  end-page: 1822
  ident: bb0235
  article-title: Assessment of ventricular function and mass by cardiac magnetic resonance imaging
  publication-title: Eur Radiol
– volume: 54
  start-page: 1084
  year: 2009
  end-page: 1091
  ident: bb0570
  article-title: Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies
  publication-title: Hypertension
– volume: 29
  start-page: 51
  year: 2016
  end-page: 61
  ident: bb0180
  article-title: Normal values of left ventricular mass index assessed by transthoracic three-dimensional echocardiography
  publication-title: J Am Soc Echocardiogr
– volume: 26
  start-page: 343
  year: 2012
  end-page: 349
  ident: bb0450
  article-title: Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies
  publication-title: J Hum Hypertens
– volume: 136
  start-page: 440
  year: 2017
  end-page: 450
  ident: bb0565
  article-title: Effect of intensive blood pressure lowering on left ventricular hypertrophy in patients with hypertension
  publication-title: Circulation
– volume: 115
  start-page: 41
  year: 2003
  end-page: 46
  ident: bb0650
  article-title: A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension
  publication-title: Am J Med
– volume: 55
  start-page: 270
  year: 2010
  ident: bb0380
  article-title: Sympathetic nervous system modulation of inflammation and remodeling in the hypertensive heart
  publication-title: Hypertension.
– volume: 110
  start-page: 2175
  year: 2004
  end-page: 2179
  ident: bb0725
  article-title: Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction
  publication-title: Circulation
– volume: 33
  start-page: 24
  year: 2015
  end-page: 32
  ident: bb0305
  article-title: White-coat hypertension, as defined by ambulatory blood pressure monitoring, and subclinical cardiac organ damage
  publication-title: J Hypertens
– volume: 20
  start-page: 1507
  year: 2018
  end-page: 1515
  ident: bb0675
  article-title: Hydrochlorothiazide vs chlorthalidone, indapamide, and potassium-sparing/hydrochlorothiazide diuretics for reducing left ventricular hypertrophy: a systematic review and meta-analysis
  publication-title: J Clin Hypertens
– volume: 12
  start-page: 579.e1
  year: 2018
  end-page: 579.e73
  ident: bb0020
  article-title: 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary
  publication-title: J Am Soc Hypertens
– volume: 108
  start-page: 997
  year: 2011
  end-page: 1001
  ident: bb0470
  article-title: Progression from normal to reduced left ventricular ejection fraction in patients with concentric left ventricular hypertrophy after long-term follow-up
  publication-title: Am J Cardiol
– volume: 3
  start-page: 735
  year: 1990
  end-page: 740
  ident: bb0375
  article-title: Ventricular arrhythmias in hypertensive left ventricular hypertrophy
  publication-title: Am J Hypertens
– volume: 72
  start-page: 549
  year: 2018
  end-page: 558
  ident: bb0365
  article-title: Myocardial remodeling in hypertension toward a new view of hypertensive heart disease
  publication-title: Hypertension.
– volume: 31
  start-page: 693
  year: 2013
  end-page: 700
  ident: bb0255
  article-title: MRI differentiation of cardiomyopathy showing left ventricular hypertrophy and heart failure: differentiation between cardiac amyloidosis, hypertrophic cardiomyopathy, and hypertensive heart disease
  publication-title: Jpn J Radiol
– volume: 36
  start-page: 1858
  year: 2018
  end-page: 1864
  ident: bb0530
  article-title: Covariables and types of abnormal left ventricular geometry in nonelderly ischemic stroke survivors: the Norwegian Stroke in the Young Study
  publication-title: J Hypertens
– volume: 14
  start-page: 746
  year: 2008
  end-page: 753
  ident: bb0720
  article-title: Xanthine oxidase inhibition with Febuxostat attenuates systolic overload-induced left ventricular hypertrophy and dysfunction in mice
  publication-title: J Card Fail
– volume: 7
  start-page: 551
  year: 2005
  end-page: 558
  ident: bb0245
  article-title: Differentiation of athlete’s heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance
  publication-title: J Cardiovasc Magn Reson
– volume: 21
  start-page: 372
  year: 2019
  end-page: 378
  ident: bb0065
  article-title: Electrocardiographic criteria for the diagnosis of abnormal hypertensive cardiac phenotypes
  publication-title: J Clin Hypertens
– volume: 272
  start-page: 33
  year: 1994
  end-page: 36
  ident: bb0525
  article-title: Left ventricular mass and risk of stroke in an elderly cohort. The Framingham Heart Study
  publication-title: JAMA
– volume: 6
  start-page: 23
  year: 2017
  end-page: 28
  ident: bb0080
  article-title: Combining ECG criteria for left ventricular hypertrophy improves risk prediction in patients with hypertension
  publication-title: J Am Heart Assoc
– volume: 37
  start-page: 24
  year: 2016
  end-page: 34
  ident: bb0400
  article-title: Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes
  publication-title: Eur Heart J
– volume: 37
  start-page: 1196
  year: 2016
  end-page: 1207
  ident: bb0190
  article-title: Myocardial strain imaging: how useful is it in clinical decision making?
  publication-title: Eur Heart J
– volume: 22
  start-page: 1382
  year: 2011
  end-page: 1389
  ident: bb0735
  article-title: Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease
  publication-title: J Am Soc Nephrol
– volume: 98
  start-page: 1442
  year: 2012
  end-page: 1448
  ident: bb0220
  article-title: Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis
  publication-title: Heart.
– volume: 270
  start-page: 302
  year: 2018
  end-page: 308
  ident: bb0280
  article-title: Pre-hypertension and subclinical cardiac damage: a meta-analysis of echocardiographic studies
  publication-title: Int J Cardiol
– volume: 130
  start-page: 1692
  year: 2014
  end-page: 1699
  ident: bb0015
  article-title: Hypertension in the United States, 1999 to 2012
  publication-title: Circulation
– volume: 13
  start-page: 321
  year: 2016
  end-page: 332
  ident: bb0405
  article-title: Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis
  publication-title: Nat Rev Cardiol
– volume: 19
  start-page: 1167
  year: 2001
  end-page: 1176
  ident: bb0670
  article-title: Regression of left ventricular hypertrophy in human hypertension with irbesartan
  publication-title: J Hypertens
– volume: 314
  start-page: 334
  year: 1986
  end-page: 339
  ident: bb0585
  article-title: The effect of weight reduction on left ventricular mass
  publication-title: N Engl J Med
– volume: 30
  start-page: 1049
  year: 2017
  end-page: 1058
  ident: bb0160
  article-title: Feasibility and accuracy of automated software for transthoracic three-dimensional left ventricular volume and function analysis: comparisons with two-dimensional echocardiography, three-dimensional transthoracic manual method, and cardiac magnetic resona
  publication-title: J Am Soc Echocardiogr
– volume: 186
  start-page: S357
  year: 2006
  end-page: S365
  ident: bb0095
  article-title: Cardiovascular function in multi-ethnic study of atherosclerosis: Normal values by age, sex, and ethnicity
  publication-title: Am J Roentgenol
– volume: 94
  start-page: 1383
  year: 2004
  end-page: 1390
  ident: bb0390
  article-title: Comparison of the prognostic value of left ventricular hypertrophy in African-American men versus women
  publication-title: Am J Cardiol
– volume: 39
  start-page: 3021
  year: 2018
  end-page: 3104
  ident: bb0060
  article-title: 2018 ESC / ESH guidelines for the management of arterial hypertension - the task force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)
  publication-title: Eur Heart J
– volume: 61
  start-page: 77
  year: 2013
  end-page: 84
  ident: bb0140
  article-title: Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes
  publication-title: J Am Coll Cardiol
– volume: 6
  year: 2017
  ident: bb0580
  article-title: Left ventricular hypertrophy regression during antihypertensive treatment in an outpatient clinic (the Campania salute network)
  publication-title: J Am Heart Assoc
– volume: 377
  start-page: 644
  year: 2017
  end-page: 657
  ident: bb0700
  article-title: Canagliflozin and cardiovascular and renal events in type 2 diabetes
  publication-title: N Engl J Med
– volume: 383
  year: 2014
  ident: bb0005
  article-title: Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy Life-years lost, and age-specific associations in 1·25 million
  publication-title: People
– volume: 57
  start-page: 3
  year: 2014
  end-page: 9
  ident: bb0035
  article-title: Impact of echocardiographic left ventricular geometry on clinical prognosis
  publication-title: Prog Cardiovasc Dis
– volume: 36
  start-page: 312
  year: 2019
  end-page: 319
  ident: bb0165
  article-title: Automated, machine learning-based, 3D echocardiographic quantification of left ventricular mass
  publication-title: Echocardiography
– volume: 8
  start-page: 1260
  year: 2015
  end-page: 1269
  ident: bb0445
  article-title: Precursors of hypertensive heart phenotype develop in healthy adults a high-resolution 3D MRI study
  publication-title: JACC Cardiovasc Imaging
– volume: 8
  year: 2019
  ident: bb0070
  article-title: Detection of left ventricular hypertrophy using Bayesian additive regression trees: the MESA
  publication-title: J Am Heart Assoc
– volume: 104
  start-page: 1248
  year: 2007
  end-page: 1254
  ident: bb0605
  article-title: Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension
  publication-title: Circulation.
– volume: 90
  start-page: 1786
  year: 1994
  end-page: 1793
  ident: bb0555
  article-title: Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy
  publication-title: Circulation
– volume: 9
  start-page: 695
  year: 2018
  end-page: 707
  ident: bb0250
  article-title: Differential diagnosis of thickened myocardium: an illustrative MRI review
  publication-title: Insights Imaging
– volume: 19
  start-page: 1550
  year: 1992
  end-page: 1558
  ident: bb0025
  article-title: Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension
  publication-title: J Am Coll Cardiol
– volume: 30
  start-page: 914
  year: 2017
  end-page: 922
  ident: bb0075
  article-title: Electrocardiographic left ventricular hypertrophy predicts cardiovascular morbidity and mortality in hypertensive patients: the ALLHAT study
  publication-title: Am J Hypertens
– volume: 40
  start-page: 606
  year: 2017
  end-page: 612
  ident: bb0285
  article-title: The influence of prehypertension, controlled and uncontrolled hypertension on left ventricular diastolic function and structure in the general Korean population
  publication-title: Hypertens Res
– volume: 4
  start-page: 27
  year: 2019
  end-page: 37
  ident: bb0055
  article-title: Empagliflozin improves diastolic function in a nondiabetic rodent model of heart failure with preserved ejection fraction
  publication-title: JACC Basic to Transl Sci
– volume: 5
  start-page: 543
  year: 2017
  end-page: 551
  ident: bb0440
  article-title: The transition from hypertension to heart failure: contemporary update
  publication-title: JACC Hear Fail
– volume: 25
  start-page: 525
  year: 2003
  end-page: 535
  ident: bb0665
  article-title: Effects of calcium channel antagonists on left ventricular hypertrophy and diastolic function in patients with essential hypertension
  publication-title: Clin Exp Hypertens
– volume: 61
  start-page: 926
  year: 2013
  end-page: 932
  ident: bb0730
  article-title: High-dose allopurinol reduces left ventricular mass in patients with ischemic heart disease
  publication-title: J Am Coll Cardiol
– volume: 39
  start-page: 1055
  year: 2002
  end-page: 1060
  ident: bb0100
  article-title: Gender differences and normal left ventricular anatomy in an adult population free of hypertension. A cardiovascular magnetic resonance study of the Framingham Heart Study Offspring cohort
  publication-title: J Am Coll Cardiol
– volume: 27
  start-page: 858
  year: 2014
  end-page: 871.e1
  ident: bb0175
  article-title: Left ventricular myocardial strain by three-dimensional speckle-tracking echocardiography in healthy subjects: reference values and analysis of their physiologic and technical determinants
  publication-title: J Am Soc Echocardiogr
– volume: 100
  start-page: 128
  year: 2007
  end-page: 132
  ident: bb0205
  article-title: An ultrasound speckle tracking (two-dimensional strain) analysis of myocardial deformation in professional soccer players compared with healthy subjects and hypertrophic cardiomyopathy
  publication-title: Am J Cardiol
– volume: 73
  start-page: 612
  year: 2019
  end-page: 619
  ident: bb0290
  article-title: High normal blood pressure and left ventricular hypertrophy echocardiographic findings from the PAMELA population
  publication-title: Hypertension.
– volume: 37
  start-page: 674
  year: 2015
  end-page: 679
  ident: bb0495
  article-title: Left ventricular hypertrophy on long-term cardiovascular outcomes in patients with ST-elevation myocardial infarction
  publication-title: Clin Exp Hypertens
– volume: 144
  start-page: 530
  year: 2002
  end-page: 537
  ident: bb0240
  article-title: Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy
  publication-title: Am Heart J
– volume: 9
  start-page: 595
  year: 1991
  end-page: 599
  ident: bb0655
  article-title: Converting enzyme inhibitors regressed cardiac hypertrophy and reduced tissue angiotensin II in spontaneously hypertensive rats
  publication-title: J Hypertens
– volume: 28
  start-page: 727
  year: 2015
  end-page: 754
  ident: bb0130
  article-title: Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)
  publication-title: J Am Soc Echocardiogr
– volume: 117
  start-page: 89
  year: 2015
  end-page: 98
  ident: bb0345
  article-title: Cardiac nonmyocytes in the hub of cardiac hypertrophy
  publication-title: Circ Res
– volume: 104
  start-page: 1615
  year: 2001
  end-page: 1621
  ident: bb0040
  article-title: Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril
  publication-title: Circulation
– volume: 14
  start-page: 13
  year: 2012
  ident: bb0260
  article-title: Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy
  publication-title: J Cardiovasc Magn Reson
– volume: 97
  year: 2018
  ident: bb0490
  article-title: Impact of left ventricular hypertrophy on long-term clinical outcomes in hypertensive patients who underwent successful percutaneous coronary intervention with drug-eluting stents
  publication-title: Medicine (Baltimore)
– volume: 373
  start-page: 2117
  year: 2015
  end-page: 2128
  ident: bb0695
  article-title: Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes
  publication-title: N Engl J Med
– volume: 266
  start-page: 231
  year: 1991
  end-page: 236
  ident: bb0115
  article-title: The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study
  publication-title: JAMA
– volume: 110
  start-page: 445
  year: 2012
  end-page: 452
  ident: bb0145
  article-title: Meta-analysis of accuracy of left ventricular mass measurement by three-dimensional echocardiography
  publication-title: Am J Cardiol
– volume: 30
  start-page: 225
  year: 2009
  end-page: 232
  ident: bb0595
  article-title: Regular physical activity prevents development of left ventricular hypertrophy in hypertension
  publication-title: Eur Heart J
– volume: 105
  start-page: 648
  issue: 8
  year: 2016
  ident: 10.1016/j.pcad.2019.11.009_bb0750
  article-title: Reductions of left ventricular mass and atrial size following renal denervation: a meta-analysis
  publication-title: Clin Res Cardiol
  doi: 10.1007/s00392-016-0964-2
– volume: 36
  start-page: 1858
  issue: 9
  year: 2018
  ident: 10.1016/j.pcad.2019.11.009_bb0530
  article-title: Covariables and types of abnormal left ventricular geometry in nonelderly ischemic stroke survivors: the Norwegian Stroke in the Young Study
  publication-title: J Hypertens
  doi: 10.1097/HJH.0000000000001772
– volume: 6
  start-page: 23
  issue: 11
  year: 2017
  ident: 10.1016/j.pcad.2019.11.009_bb0080
  article-title: Combining ECG criteria for left ventricular hypertrophy improves risk prediction in patients with hypertension
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.117.007564
– volume: 377
  start-page: 644
  issue: 7
  year: 2017
  ident: 10.1016/j.pcad.2019.11.009_bb0700
  article-title: Canagliflozin and cardiovascular and renal events in type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1611925
– volume: 104
  start-page: 1248
  issue: 11
  year: 2007
  ident: 10.1016/j.pcad.2019.11.009_bb0605
  article-title: Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension
  publication-title: Circulation.
  doi: 10.1161/hc3601.095927
– volume: 21
  start-page: 372
  issue: 3
  year: 2019
  ident: 10.1016/j.pcad.2019.11.009_bb0065
  article-title: Electrocardiographic criteria for the diagnosis of abnormal hypertensive cardiac phenotypes
  publication-title: J Clin Hypertens
  doi: 10.1111/jch.13486
– volume: 12
  start-page: 579.e1
  issue: 8
  year: 2018
  ident: 10.1016/j.pcad.2019.11.009_bb0020
  article-title: 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary
  publication-title: J Am Soc Hypertens
  doi: 10.1016/j.jash.2018.06.010
– volume: 13
  start-page: 321
  issue: 6
  year: 2016
  ident: 10.1016/j.pcad.2019.11.009_bb0405
  article-title: Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis
  publication-title: Nat Rev Cardiol
  doi: 10.1038/nrcardio.2016.45
– volume: 3
  start-page: 266
  issue: 3
  year: 2010
  ident: 10.1016/j.pcad.2019.11.009_bb0110
  article-title: The impact of obesity on the left ventricle
  publication-title: JACC Cardiovasc Imaging
  doi: 10.1016/j.jcmg.2009.10.012
– volume: 76
  start-page: 1177
  issue: 5
  year: 2012
  ident: 10.1016/j.pcad.2019.11.009_bb0170
  article-title: Normal values of real-time 3-dimensional echocardiographic parameters in a healthy Japanese population: the JAMP-3D study
  publication-title: Circ J
  doi: 10.1253/circj.CJ-11-1256
– volume: 288
  start-page: 2981
  issue: 23
  year: 2002
  ident: 10.1016/j.pcad.2019.11.009_bb0620
  publication-title: JAMA.
  doi: 10.1001/jama.288.23.2981
– volume: 6
  issue: 1
  year: 2017
  ident: 10.1016/j.pcad.2019.11.009_bb0500
  article-title: Left ventricular hypertrophy is associated with increased infarct size and decreased myocardial salvage in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.116.004823
– volume: 79
  start-page: 215
  issue: 1
  year: 1999
  ident: 10.1016/j.pcad.2019.11.009_bb0340
  article-title: Molecular mechanisms of myocardial remodeling
  publication-title: Physiol Rev
  doi: 10.1152/physrev.1999.79.1.215
– volume: 7
  start-page: 551
  issue: 3
  year: 2005
  ident: 10.1016/j.pcad.2019.11.009_bb0245
  article-title: Differentiation of athlete’s heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance
  publication-title: J Cardiovasc Magn Reson
  doi: 10.1081/JCMR-200060631
– volume: 90
  start-page: 1786
  issue: 4 I
  year: 1994
  ident: 10.1016/j.pcad.2019.11.009_bb0555
  article-title: Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy
  publication-title: Circulation
  doi: 10.1161/01.CIR.90.4.1786
– volume: 33
  start-page: 24
  issue: 1
  year: 2015
  ident: 10.1016/j.pcad.2019.11.009_bb0305
  article-title: White-coat hypertension, as defined by ambulatory blood pressure monitoring, and subclinical cardiac organ damage
  publication-title: J Hypertens
  doi: 10.1097/HJH.0000000000000416
– volume: 49
  start-page: 1385
  issue: 6
  year: 2007
  ident: 10.1016/j.pcad.2019.11.009_bb0480
  article-title: Left ventricular hypertrophy, subclinical atherosclerosis, and inflammation
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.107.087890
– volume: 2
  start-page: 1025
  issue: 9
  year: 2017
  ident: 10.1016/j.pcad.2019.11.009_bb0715
  article-title: Effects of sodium-glucose Cotransporter 2 inhibitors for the treatment of patients with heart failure
  publication-title: JAMA Cardiol
  doi: 10.1001/jamacardio.2017.2275
– volume: 88
  start-page: 993
  issue: 3
  year: 1993
  ident: 10.1016/j.pcad.2019.11.009_bb0370
  article-title: Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension
  publication-title: Circulation.
  doi: 10.1161/01.CIR.88.3.993
– volume: 26
  start-page: 343
  issue: 6
  year: 2012
  ident: 10.1016/j.pcad.2019.11.009_bb0450
  article-title: Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies
  publication-title: J Hum Hypertens
  doi: 10.1038/jhh.2011.104
– volume: 378
  start-page: 1509
  issue: 16
  year: 2018
  ident: 10.1016/j.pcad.2019.11.009_bb0295
  article-title: Relationship between clinic and ambulatory blood-pressure measurements and mortality
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1712231
– volume: 95
  start-page: 1464
  issue: 6
  year: 1997
  ident: 10.1016/j.pcad.2019.11.009_bb0320
  article-title: Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE study group. Study on ambulatory monitoring of blood pressure and Lisinopril evaluation
  publication-title: Circulation.
  doi: 10.1161/01.CIR.95.6.1464
– volume: 30
  start-page: 71
  year: 2011
  ident: 10.1016/j.pcad.2019.11.009_bb0185
  article-title: Speckle-tracking echocardiography: a new technique for assessing myocardial function
  publication-title: J Ultrasound Med
  doi: 10.7863/jum.2011.30.1.71
– volume: 117
  start-page: 89
  issue: 1
  year: 2015
  ident: 10.1016/j.pcad.2019.11.009_bb0345
  article-title: Cardiac nonmyocytes in the hub of cardiac hypertrophy
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.117.305349
– volume: 26
  start-page: 343
  issue: 6
  year: 2012
  ident: 10.1016/j.pcad.2019.11.009_bb0270
  article-title: Italian Society of Hypertension. Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies
  publication-title: J Hum Hypertens
  doi: 10.1038/jhh.2011.104
– volume: 8
  issue: 5
  year: 2019
  ident: 10.1016/j.pcad.2019.11.009_bb0070
  article-title: Detection of left ventricular hypertrophy using Bayesian additive regression trees: the MESA
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.118.009959
– volume: 186
  start-page: S357
  issue: 6_supplement_2
  year: 2006
  ident: 10.1016/j.pcad.2019.11.009_bb0095
  article-title: Cardiovascular function in multi-ethnic study of atherosclerosis: Normal values by age, sex, and ethnicity
  publication-title: Am J Roentgenol
  doi: 10.2214/AJR.04.1868
– volume: 30
  start-page: 225
  issue: 2
  year: 2009
  ident: 10.1016/j.pcad.2019.11.009_bb0595
  article-title: Regular physical activity prevents development of left ventricular hypertrophy in hypertension
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehn533
– volume: 94
  start-page: 1383
  issue: 11
  year: 2004
  ident: 10.1016/j.pcad.2019.11.009_bb0390
  article-title: Comparison of the prognostic value of left ventricular hypertrophy in African-American men versus women
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2004.08.012
– volume: 97
  issue: 35
  year: 2018
  ident: 10.1016/j.pcad.2019.11.009_bb0490
  article-title: Impact of left ventricular hypertrophy on long-term clinical outcomes in hypertensive patients who underwent successful percutaneous coronary intervention with drug-eluting stents
  publication-title: Medicine (Baltimore)
  doi: 10.1097/MD.0000000000012067
– volume: 14
  start-page: 746
  issue: 9
  year: 2008
  ident: 10.1016/j.pcad.2019.11.009_bb0720
  article-title: Xanthine oxidase inhibition with Febuxostat attenuates systolic overload-induced left ventricular hypertrophy and dysfunction in mice
  publication-title: J Card Fail
  doi: 10.1016/j.cardfail.2008.06.006
– volume: 8
  start-page: 1
  issue: 8
  year: 2019
  ident: 10.1016/j.pcad.2019.11.009_bb0630
  article-title: Prevention of heart failure in hypertension—disentangling the role of evolving left ventricular hypertrophy and blood pressure lowering: the ALLHAT study
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.119.011961
– volume: 19
  start-page: 149
  issue: 2
  year: 2005
  ident: 10.1016/j.pcad.2019.11.009_bb0360
  article-title: Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-α) and essential hypertension
  publication-title: J Hum Hypertens
  doi: 10.1038/sj.jhh.1001785
– volume: 20
  start-page: 1507
  issue: 10
  year: 2018
  ident: 10.1016/j.pcad.2019.11.009_bb0675
  article-title: Hydrochlorothiazide vs chlorthalidone, indapamide, and potassium-sparing/hydrochlorothiazide diuretics for reducing left ventricular hypertrophy: a systematic review and meta-analysis
  publication-title: J Clin Hypertens
  doi: 10.1111/jch.13386
– volume: 56
  start-page: 563
  issue: 4
  year: 2010
  ident: 10.1016/j.pcad.2019.11.009_bb0120
  article-title: Noninvasive evaluation of left ventricular afterload
  publication-title: Hypertension.
  doi: 10.1161/HYPERTENSIONAHA.110.157339
– volume: 28
  start-page: 727
  year: 2015
  ident: 10.1016/j.pcad.2019.11.009_bb0130
  article-title: Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)
  publication-title: J Am Soc Echocardiogr
  doi: 10.1016/j.echo.2015.05.002
– volume: 2
  start-page: 191
  issue: 3
  year: 2009
  ident: 10.1016/j.pcad.2019.11.009_bb0105
  article-title: Age-related left ventricular remodeling and associated risk for cardiovascular outcomes
  publication-title: Circ Cardiovasc Imaging
  doi: 10.1161/CIRCIMAGING.108.819938
– volume: 54
  start-page: 1084
  issue: 5
  year: 2009
  ident: 10.1016/j.pcad.2019.11.009_bb0570
  article-title: Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.109.136655
– volume: 4
  start-page: 98
  issue: 1
  year: 2011
  ident: 10.1016/j.pcad.2019.11.009_bb0755
  article-title: Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment
  publication-title: JACC Cardiovasc Imaging
  doi: 10.1016/j.jcmg.2010.10.008
– volume: 123
  start-page: 274
  issue: 2
  year: 2019
  ident: 10.1016/j.pcad.2019.11.009_bb0275
  article-title: Interrelations between hypertension and electrocardiographic left ventricular hypertrophy and their associations with cardiovascular mortality
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2018.10.006
– volume: 3
  start-page: 735
  year: 1990
  ident: 10.1016/j.pcad.2019.11.009_bb0375
  article-title: Ventricular arrhythmias in hypertensive left ventricular hypertrophy
  publication-title: Am J Hypertens
  doi: 10.1093/ajh/3.10.735
– volume: 29
  start-page: 277
  issue: 4
  year: 2016
  ident: 10.1016/j.pcad.2019.11.009_bb0455
  article-title: Recommendations for the evaluation of left ventricular diastolic function by Echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
  publication-title: J Am Soc Echocardiogr
  doi: 10.1016/j.echo.2016.01.011
– volume: 370
  start-page: 1393
  issue: 15
  year: 2014
  ident: 10.1016/j.pcad.2019.11.009_bb0745
  article-title: A controlled trial of renal denervation for resistant hypertension
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1402670
– volume: 13
  start-page: 730
  issue: 9
  year: 2012
  ident: 10.1016/j.pcad.2019.11.009_bb0200
  article-title: Correlates of global area strain in native hypertensive patients: a three-dimensional speckle-tracking echocardiography study
  publication-title: Eur Heart J Cardiovasc Imaging
  doi: 10.1093/ehjci/jes026
– volume: 53
  start-page: 284
  issue: 3
  year: 2009
  ident: 10.1016/j.pcad.2019.11.009_bb0265
  article-title: Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2008.08.064
– volume: 55
  start-page: 270
  issue: 2
  year: 2010
  ident: 10.1016/j.pcad.2019.11.009_bb0380
  article-title: Sympathetic nervous system modulation of inflammation and remodeling in the hypertensive heart
  publication-title: Hypertension.
  doi: 10.1161/HYPERTENSIONAHA.109.142042
– volume: 27
  start-page: 858
  issue: 8
  year: 2014
  ident: 10.1016/j.pcad.2019.11.009_bb0175
  article-title: Left ventricular myocardial strain by three-dimensional speckle-tracking echocardiography in healthy subjects: reference values and analysis of their physiologic and technical determinants
  publication-title: J Am Soc Echocardiogr
  doi: 10.1016/j.echo.2014.05.010
– volume: 14
  start-page: 1813
  issue: 10
  year: 2004
  ident: 10.1016/j.pcad.2019.11.009_bb0235
  article-title: Assessment of ventricular function and mass by cardiac magnetic resonance imaging
  publication-title: Eur Radiol
  doi: 10.1007/s00330-004-2387-0
– volume: 383
  year: 2014
  ident: 10.1016/j.pcad.2019.11.009_bb0005
  article-title: Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy Life-years lost, and age-specific associations in 1·25 million
  publication-title: People
– volume: 108
  start-page: 1831
  issue: 15
  year: 2003
  ident: 10.1016/j.pcad.2019.11.009_bb0610
  article-title: Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study
  publication-title: Circulation.
  doi: 10.1161/01.CIR.0000091405.00772.6E
– volume: 144
  start-page: 530
  issue: 3
  year: 2002
  ident: 10.1016/j.pcad.2019.11.009_bb0240
  article-title: Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy
  publication-title: Am Heart J
  doi: 10.1067/mhj.2002.124863
– volume: 116
  start-page: 1022
  issue: 6
  year: 2015
  ident: 10.1016/j.pcad.2019.11.009_bb0350
  article-title: Inflammation, immunity, and hypertensive end-organ damage
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.116.303697
– volume: 100
  start-page: 128
  issue: 1
  year: 2007
  ident: 10.1016/j.pcad.2019.11.009_bb0205
  article-title: An ultrasound speckle tracking (two-dimensional strain) analysis of myocardial deformation in professional soccer players compared with healthy subjects and hypertrophic cardiomyopathy
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2007.02.063
– volume: 98
  start-page: 1442
  issue: 19
  year: 2012
  ident: 10.1016/j.pcad.2019.11.009_bb0220
  article-title: Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis
  publication-title: Heart.
  doi: 10.1136/heartjnl-2012-302353
– volume: 22
  start-page: 1382
  issue: 7
  year: 2011
  ident: 10.1016/j.pcad.2019.11.009_bb0735
  article-title: Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2010111185
– volume: 29
  start-page: 1439
  issue: 7
  year: 2011
  ident: 10.1016/j.pcad.2019.11.009_bb0615
  article-title: Effects of perindopril-indapamide on left ventricular diastolic function and mass in patients with type 2 diabetes: the ADVANCE Echocardiography Substudy
  publication-title: J Hypertens
  doi: 10.1097/HJH.0b013e3283480fe9
– volume: 19
  start-page: 1146
  issue: 7
  year: 2017
  ident: 10.1016/j.pcad.2019.11.009_bb0425
  article-title: Left-ventricular geometry and risk of sudden cardiac arrest in patients with preserved or moderately reduced left-ventricular ejection fraction
  publication-title: Europace.
– volume: 359
  start-page: 995
  issue: 9311
  year: 2002
  ident: 10.1016/j.pcad.2019.11.009_bb0045
  article-title: Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
  publication-title: Lancet
  doi: 10.1016/S0140-6736(02)08089-3
– volume: 36
  start-page: 140
  issue: 2
  year: 2016
  ident: 10.1016/j.pcad.2019.11.009_bb0010
  article-title: A randomized trial of intensive versus standard blood-pressure control
  publication-title: N Engl J Med
– volume: 27
  start-page: 460
  issue: 4
  year: 2006
  ident: 10.1016/j.pcad.2019.11.009_bb0135
  article-title: Rapid online quantification of left ventricular volume from real-time three-dimensional echocardiographic data
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehi666
– volume: 73
  start-page: 612
  issue: 3
  year: 2019
  ident: 10.1016/j.pcad.2019.11.009_bb0290
  article-title: High normal blood pressure and left ventricular hypertrophy echocardiographic findings from the PAMELA population
  publication-title: Hypertension.
  doi: 10.1161/HYPERTENSIONAHA.118.12114
– volume: 73
  start-page: 736
  issue: 3
  year: 2019
  ident: 10.1016/j.pcad.2019.11.009_bb0335
  article-title: Unattended versus attended blood pressure measurement
  publication-title: Hypertension.
  doi: 10.1161/HYPERTENSIONAHA.118.12187
– volume: 52
  start-page: 2148
  issue: 25
  year: 2008
  ident: 10.1016/j.pcad.2019.11.009_bb0535
  article-title: The relationship of left ventricular mass and geometry to incident cardiovascular events
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2008.09.014
– volume: 28
  start-page: 649
  issue: 6
  year: 2011
  ident: 10.1016/j.pcad.2019.11.009_bb0195
  article-title: Left ventricular function in hypertension: new insight by speckle tracking echocardiography
  publication-title: Echocardiography
  doi: 10.1111/j.1540-8175.2011.01410.x
– volume: 71
  start-page: 429
  issue: 3
  year: 2018
  ident: 10.1016/j.pcad.2019.11.009_bb0550
  article-title: Left ventricular hypertrophy and remodeling and risk of cognitive impairment and dementia: MESA (multi-ethnic study of atherosclerosis)
  publication-title: Hypertension.
  doi: 10.1161/HYPERTENSIONAHA.117.10289
– volume: 59
  start-page: 1333
  issue: 7
  year: 2016
  ident: 10.1016/j.pcad.2019.11.009_bb0710
  article-title: SGLT2 inhibition and cardiovascular events: why did EMPA-REG outcomes surprise and what were the likely mechanisms?
  publication-title: Diabetologia.
  doi: 10.1007/s00125-016-3956-x
– volume: 9
  start-page: 595
  issue: 7
  year: 1991
  ident: 10.1016/j.pcad.2019.11.009_bb0655
  article-title: Converting enzyme inhibitors regressed cardiac hypertrophy and reduced tissue angiotensin II in spontaneously hypertensive rats
  publication-title: J Hypertens
  doi: 10.1097/00004872-199107000-00003
– volume: 270
  start-page: 302
  year: 2018
  ident: 10.1016/j.pcad.2019.11.009_bb0280
  article-title: Pre-hypertension and subclinical cardiac damage: a meta-analysis of echocardiographic studies
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2018.06.031
– volume: 16
  start-page: 147
  issue: 2
  year: 2004
  ident: 10.1016/j.pcad.2019.11.009_bb0540
  article-title: Left ventricular hypertrophy and blood pressure as predictors of cognitive decline in old age
  publication-title: Aging Clin Exp Res
  doi: 10.1007/BF03324544
– volume: 20
  start-page: 1251
  issue: 5
  year: 1992
  ident: 10.1016/j.pcad.2019.11.009_bb0125
  article-title: Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight
  publication-title: J Am Coll Cardiol
  doi: 10.1016/0735-1097(92)90385-Z
– volume: 37
  start-page: 24
  issue: 1
  year: 2016
  ident: 10.1016/j.pcad.2019.11.009_bb0400
  article-title: Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehv598
– volume: 61
  start-page: 77
  issue: 1
  year: 2013
  ident: 10.1016/j.pcad.2019.11.009_bb0140
  article-title: Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2012.09.035
– volume: 30
  start-page: 1289
  issue: 7
  year: 2012
  ident: 10.1016/j.pcad.2019.11.009_bb0325
  article-title: Home versus ambulatory and office blood pressure in predicting target organ damage in hypertension: a systematic review and meta-analysis
  publication-title: J Hypertens
  doi: 10.1097/HJH.0b013e3283531eaf
– volume: 38
  start-page: 3308
  issue: 44
  year: 2017
  ident: 10.1016/j.pcad.2019.11.009_bb0640
  article-title: The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehx525
– volume: 37
  start-page: 1815
  issue: 7
  year: 2014
  ident: 10.1016/j.pcad.2019.11.009_bb0690
  article-title: Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with Empagliflozin added to titrated multiple daily injections of insulin in obese inadequately controlled type 2 diabetes
  publication-title: Diabetes Care
  doi: 10.2337/dc13-3055
– volume: 19
  start-page: 47
  issue: 1
  year: 2018
  ident: 10.1016/j.pcad.2019.11.009_bb0155
  article-title: Three-dimensional echocardiographic quantification of the left-heart chambers using an automated adaptive analytics algorithm: multicentre validation study
  publication-title: Eur Hear J - Cardiovasc Imaging
  doi: 10.1093/ehjci/jew328
– volume: 18
  start-page: 945
  year: 2017
  ident: 10.1016/j.pcad.2019.11.009_bb0230
  publication-title: Eur Heart J Cardiovasc Imaging
  doi: 10.1093/ehjci/jex094
– volume: 57
  start-page: 3
  issue: 1
  year: 2014
  ident: 10.1016/j.pcad.2019.11.009_bb0035
  article-title: Impact of echocardiographic left ventricular geometry on clinical prognosis
  publication-title: Prog Cardiovasc Dis
  doi: 10.1016/j.pcad.2014.05.003
– volume: 114
  start-page: 1049
  issue: 7
  year: 2014
  ident: 10.1016/j.pcad.2019.11.009_bb0520
  article-title: Meta-analysis of left ventricular hypertrophy and sustained arrhythmias
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2014.07.015
– volume: 39
  start-page: 1055
  issue: 6
  year: 2002
  ident: 10.1016/j.pcad.2019.11.009_bb0100
  article-title: Gender differences and normal left ventricular anatomy in an adult population free of hypertension. A cardiovascular magnetic resonance study of the Framingham Heart Study Offspring cohort
  publication-title: J Am Coll Cardiol
  doi: 10.1016/S0735-1097(02)01712-6
– volume: 322
  start-page: 1561
  issue: 22
  year: 1990
  ident: 10.1016/j.pcad.2019.11.009_bb0385
  article-title: DS. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199005313222203
– volume: 115
  start-page: 41
  issue: 1
  year: 2003
  ident: 10.1016/j.pcad.2019.11.009_bb0650
  article-title: A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension
  publication-title: Am J Med
  doi: 10.1016/S0002-9343(03)00158-X
– volume: 62
  start-page: e147
  issue: 16
  year: 2013
  ident: 10.1016/j.pcad.2019.11.009_bb0435
  article-title: 2013 ACCF/AHA guideline for the management of heart failure
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2013.05.019
– volume: 27
  start-page: 146
  issue: 2
  year: 2014
  ident: 10.1016/j.pcad.2019.11.009_bb0590
  article-title: Effects of bariatric surgery on cardiac structure and function: a systematic review and meta-analysis
  publication-title: Am J Hypertens
  doi: 10.1093/ajh/hpt215
– volume: 56
  start-page: e50
  issue: 25
  year: 2010
  ident: 10.1016/j.pcad.2019.11.009_bb0030
  article-title: 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2010.09.001
– volume: 6
  issue: 4
  year: 2017
  ident: 10.1016/j.pcad.2019.11.009_bb0330
  article-title: Associations of blood pressure dipping patterns with left ventricular mass and left ventricular hypertrophy in blacks: the Jackson heart study
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.116.004847
– volume: 6
  issue: 3
  year: 2017
  ident: 10.1016/j.pcad.2019.11.009_bb0580
  article-title: Left ventricular hypertrophy regression during antihypertensive treatment in an outpatient clinic (the Campania salute network)
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.116.004152
– volume: 258
  start-page: 257
  year: 2018
  ident: 10.1016/j.pcad.2019.11.009_bb0415
  article-title: Left ventricular hypertrophy offsets the sex difference in cardiovascular risk (the Campania salute network)
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2017.12.086
– volume: 29
  start-page: 51
  issue: 1
  year: 2016
  ident: 10.1016/j.pcad.2019.11.009_bb0180
  article-title: Normal values of left ventricular mass index assessed by transthoracic three-dimensional echocardiography
  publication-title: J Am Soc Echocardiogr
  doi: 10.1016/j.echo.2015.09.009
– volume: 108
  start-page: 997
  issue: 7
  year: 2011
  ident: 10.1016/j.pcad.2019.11.009_bb0470
  article-title: Progression from normal to reduced left ventricular ejection fraction in patients with concentric left ventricular hypertrophy after long-term follow-up
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2011.05.037
– volume: 45
  start-page: 1545
  issue: 5
  year: 2014
  ident: 10.1016/j.pcad.2019.11.009_bb0410
  article-title: Guidelines for the prevention of stroke in women
  publication-title: Stroke
  doi: 10.1161/01.str.0000442009.06663.48
– volume: 30
  start-page: 535
  issue: 6
  year: 2007
  ident: 10.1016/j.pcad.2019.11.009_bb0515
  article-title: Prevalence of paroxysmal atrial fibrillation depending on the regression of left ventricular hypertrophy in arterial hypertension
  publication-title: Hypertens Res
  doi: 10.1291/hypres.30.535
– volume: 37
  start-page: 1196
  issue: 15
  year: 2016
  ident: 10.1016/j.pcad.2019.11.009_bb0190
  article-title: Myocardial strain imaging: how useful is it in clinical decision making?
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehv529
– volume: 61
  start-page: 926
  issue: 9
  year: 2013
  ident: 10.1016/j.pcad.2019.11.009_bb0730
  article-title: High-dose allopurinol reduces left ventricular mass in patients with ischemic heart disease
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2012.09.066
– volume: 103
  start-page: 102
  issue: 1
  year: 2001
  ident: 10.1016/j.pcad.2019.11.009_bb0310
  article-title: Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: hypertension genetic epidemiology network (HyperGEN) study
  publication-title: Circulation.
  doi: 10.1161/01.CIR.103.1.102
– volume: 104
  start-page: 1615
  issue: 14
  year: 2001
  ident: 10.1016/j.pcad.2019.11.009_bb0040
  article-title: Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril
  publication-title: Circulation
  doi: 10.1161/hc3901.096700
– volume: 39
  start-page: e212
  issue: 12
  year: 2016
  ident: 10.1016/j.pcad.2019.11.009_bb0050
  article-title: Effect of Empagliflozin on left ventricular mass and diastolic function in individuals with diabetes: an important clue to the EMPA-REG OUTCOME trial?
  publication-title: Diabetes Care
  doi: 10.2337/dc16-1312
– volume: 130
  start-page: 1692
  issue: 19
  year: 2014
  ident: 10.1016/j.pcad.2019.11.009_bb0015
  article-title: Hypertension in the United States, 1999 to 2012
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.114.010676
– volume: 314
  start-page: 334
  issue: 6
  year: 1986
  ident: 10.1016/j.pcad.2019.11.009_bb0585
  article-title: The effect of weight reduction on left ventricular mass
  publication-title: N Engl J Med
  doi: 10.1056/NEJM198602063140602
– volume: 4
  start-page: 27
  issue: 1
  year: 2019
  ident: 10.1016/j.pcad.2019.11.009_bb0055
  article-title: Empagliflozin improves diastolic function in a nondiabetic rodent model of heart failure with preserved ejection fraction
  publication-title: JACC Basic to Transl Sci
  doi: 10.1016/j.jacbts.2018.11.010
– volume: 108
  start-page: 992
  issue: 7
  year: 2011
  ident: 10.1016/j.pcad.2019.11.009_bb0465
  article-title: Progression from concentric left ventricular hypertrophy and normal ejection fraction to left ventricular dysfunction
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2011.05.038
– volume: 62
  start-page: 2284
  issue: 24
  year: 2013
  ident: 10.1016/j.pcad.2019.11.009_bb0740
  article-title: Allopurinol reduces left ventricular mass in patients with type 2 diabetes and left ventricular hypertrophy
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2013.07.074
– volume: 266
  start-page: 231
  issue: 2
  year: 1991
  ident: 10.1016/j.pcad.2019.11.009_bb0115
  article-title: The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study
  publication-title: JAMA
  doi: 10.1001/jama.1991.03470020057032
– volume: 30
  start-page: 1049
  issue: 11
  year: 2017
  ident: 10.1016/j.pcad.2019.11.009_bb0160
  article-title: Feasibility and accuracy of automated software for transthoracic three-dimensional left ventricular volume and function analysis: comparisons with two-dimensional echocardiography, three-dimensional transthoracic manual method, and cardiac magnetic resona
  publication-title: J Am Soc Echocardiogr
  doi: 10.1016/j.echo.2017.06.026
– volume: 73
  start-page: 1071
  issue: 5
  year: 2019
  ident: 10.1016/j.pcad.2019.11.009_bb0430
  article-title: Sudden cardiac death in hypertensive patients
  publication-title: Hypertension.
  doi: 10.1161/HYPERTENSIONAHA.119.12684
– volume: 9
  start-page: 695
  issue: 5
  year: 2018
  ident: 10.1016/j.pcad.2019.11.009_bb0250
  article-title: Differential diagnosis of thickened myocardium: an illustrative MRI review
  publication-title: Insights Imaging
  doi: 10.1007/s13244-018-0655-9
– volume: 108
  start-page: 2993
  issue: 24
  year: 2003
  ident: 10.1016/j.pcad.2019.11.009_bb0355
  article-title: Blood pressure, C-reactive protein, and risk of future cardiovascular events
  publication-title: Circulation.
  doi: 10.1161/01.CIR.0000104566.10178.AF
– volume: 41
  start-page: 218
  issue: 2
  year: 2003
  ident: 10.1016/j.pcad.2019.11.009_bb0505
  article-title: Atrial fibrillation in hypertension: predictors and outcome
  publication-title: Hypertension.
  doi: 10.1161/01.HYP.0000052830.02773.E4
– volume: 28
  start-page: 1
  issue: 1
  year: 2015
  ident: 10.1016/j.pcad.2019.11.009_bb0085
  article-title: Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
  publication-title: J Am Soc Echocardiogr
  doi: 10.1016/j.echo.2014.10.003
– volume: 97
  start-page: 959
  issue: 7
  year: 2006
  ident: 10.1016/j.pcad.2019.11.009_bb0420
  article-title: Left ventricular geometry and survival in patients with normal left ventricular ejection fraction
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2005.10.030
– volume: 43
  start-page: 2207
  issue: 12
  year: 2004
  ident: 10.1016/j.pcad.2019.11.009_bb0460
  article-title: Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the cardiovascular health study
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2003.11.064
– volume: 94
  start-page: 1304
  issue: 6
  year: 1996
  ident: 10.1016/j.pcad.2019.11.009_bb0660
  article-title: Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension
  publication-title: Circulation
  doi: 10.1161/01.CIR.94.6.1304
– volume: 34
  start-page: 91
  issue: 2
  year: 2001
  ident: 10.1016/j.pcad.2019.11.009_bb0560
  article-title: Independent risk for cardiovascular disease predicted by modified continuous score electrocardiographic criteria for 6-year incidence and regression of left ventricular hypertrophy among clinically disease free men: 16-year follow-up for the multiple
  publication-title: J Electrocardiol
  doi: 10.1054/jelc.2001.23360
– volume: 40
  start-page: 606
  issue: 6
  year: 2017
  ident: 10.1016/j.pcad.2019.11.009_bb0285
  article-title: The influence of prehypertension, controlled and uncontrolled hypertension on left ventricular diastolic function and structure in the general Korean population
  publication-title: Hypertens Res
  doi: 10.1038/hr.2016.191
– volume: 48
  start-page: 87
  issue: 1
  year: 2006
  ident: 10.1016/j.pcad.2019.11.009_bb0395
  article-title: Prognostic implications of left ventricular mass among Hispanics
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000223330.03088.58
– volume: 8
  start-page: 1260
  issue: 11
  year: 2015
  ident: 10.1016/j.pcad.2019.11.009_bb0445
  article-title: Precursors of hypertensive heart phenotype develop in healthy adults a high-resolution 3D MRI study
  publication-title: JACC Cardiovasc Imaging
  doi: 10.1016/j.jcmg.2015.08.007
– volume: 39
  start-page: 3021
  year: 2018
  ident: 10.1016/j.pcad.2019.11.009_bb0060
  article-title: 2018 ESC / ESH guidelines for the management of arterial hypertension - the task force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehy339
– volume: 373
  start-page: 2117
  issue: 22
  year: 2015
  ident: 10.1016/j.pcad.2019.11.009_bb0695
  article-title: Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1504720
– volume: 31
  start-page: 693
  issue: 10
  year: 2013
  ident: 10.1016/j.pcad.2019.11.009_bb0255
  article-title: MRI differentiation of cardiomyopathy showing left ventricular hypertrophy and heart failure: differentiation between cardiac amyloidosis, hypertrophic cardiomyopathy, and hypertensive heart disease
  publication-title: Jpn J Radiol
  doi: 10.1007/s11604-013-0238-0
– volume: 2
  start-page: 1
  issue: 3
  year: 2013
  ident: 10.1016/j.pcad.2019.11.009_bb0575
  article-title: Lack of reduction of left ventricular mass in treated hypertension: the strong heart study
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.113.000144
– volume: 8
  issue: 13
  year: 2019
  ident: 10.1016/j.pcad.2019.11.009_bb0645
  article-title: Effects of the angiotensin-receptor neprilysin inhibitor on cardiac reverse remodeling: meta-analysis
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.119.012272
– volume: 36
  start-page: 1247
  issue: 6
  year: 2018
  ident: 10.1016/j.pcad.2019.11.009_bb0680
  article-title: Hydrochlorothiazide and alternative diuretics versus renin-angiotensin system inhibitors for the regression of left ventricular hypertrophy: a head-to-head meta-analysis
  publication-title: J Hypertens
  doi: 10.1097/HJH.0000000000001691
– volume: 8
  start-page: 673
  issue: 12
  year: 2011
  ident: 10.1016/j.pcad.2019.11.009_bb0090
  article-title: Cardiac remodeling at the population level—risk factors, screening, and outcomes
  publication-title: Nat Rev Cardiol
  doi: 10.1038/nrcardio.2011.154
– volume: 72
  start-page: 549
  issue: 3
  year: 2018
  ident: 10.1016/j.pcad.2019.11.009_bb0365
  article-title: Myocardial remodeling in hypertension toward a new view of hypertensive heart disease
  publication-title: Hypertension.
  doi: 10.1161/HYPERTENSIONAHA.118.11125
– volume: 108
  start-page: 1322
  issue: 9
  year: 2011
  ident: 10.1016/j.pcad.2019.11.009_bb0210
  article-title: Usefulness of two-dimensional and speckle tracking Echocardiography in “gray zone” left ventricular hypertrophy to differentiate professional football player’s heart from hypertrophic cardiomyopathy
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2011.06.053
– volume: 296
  start-page: 1242
  issue: 10
  year: 2006
  ident: 10.1016/j.pcad.2019.11.009_bb0600
  article-title: Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension
  publication-title: JAMA
  doi: 10.1001/jama.296.10.1242
– volume: 30
  start-page: 914
  issue: 9
  year: 2017
  ident: 10.1016/j.pcad.2019.11.009_bb0075
  article-title: Electrocardiographic left ventricular hypertrophy predicts cardiovascular morbidity and mortality in hypertensive patients: the ALLHAT study
  publication-title: Am J Hypertens
  doi: 10.1093/ajh/hpx067
– volume: 9
  start-page: 769
  issue: 7
  year: 2016
  ident: 10.1016/j.pcad.2019.11.009_bb0150
  article-title: Transthoracic 3D echocardiographic left heart chamber quantification using an automated adaptive analytics algorithm
  publication-title: JACC Cardiovasc Imaging
  doi: 10.1016/j.jcmg.2015.12.020
– volume: 110
  start-page: 2175
  issue: 15
  year: 2004
  ident: 10.1016/j.pcad.2019.11.009_bb0725
  article-title: Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000144303.24894.1C
– volume: 17
  start-page: 132
  issue: 1
  year: 2017
  ident: 10.1016/j.pcad.2019.11.009_bb0225
  article-title: The emerging role of cardiovascular magnetic resonance in the evaluation of hypertensive heart disease
  publication-title: BMC Cardiovasc Disord
  doi: 10.1186/s12872-017-0556-8
– volume: 37
  start-page: 674
  issue: 8
  year: 2015
  ident: 10.1016/j.pcad.2019.11.009_bb0495
  article-title: Left ventricular hypertrophy on long-term cardiovascular outcomes in patients with ST-elevation myocardial infarction
  publication-title: Clin Exp Hypertens
  doi: 10.3109/10641963.2015.1047943
– volume: 204
  start-page: 58
  year: 2018
  ident: 10.1016/j.pcad.2019.11.009_bb0545
  article-title: Association of left ventricular hypertrophy with cognitive decline and dementia risk over 20 years: the atherosclerosis risk in communities–neurocognitive study (ARIC-NCS)
  publication-title: Am Heart J
  doi: 10.1016/j.ahj.2018.07.007
– volume: 17
  start-page: 229
  issue: 1
  year: 2017
  ident: 10.1016/j.pcad.2019.11.009_bb0705
  article-title: Does dapagliflozin regress left ventricular hypertrophy in patients with type 2 diabetes? A prospective, double-blind, randomised, placebo-controlled study
  publication-title: BMC Cardiovasc Disord
  doi: 10.1186/s12872-017-0663-6
– volume: 36
  start-page: 3396
  issue: 11
  year: 2013
  ident: 10.1016/j.pcad.2019.11.009_bb0685
  article-title: Empagliflozin as add-on to metformin plus sulfonylurea in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial
  publication-title: Diabetes Care
  doi: 10.2337/dc12-2673
– volume: 286
  start-page: 1
  year: 2019
  ident: 10.1016/j.pcad.2019.11.009_bb0485
  article-title: Left ventricular hypertrophy contributes to myocardial ischemia in non-obstructive coronary artery disease (the MicroCAD study)
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2019.03.059
– volume: 28
  start-page: 806
  issue: 6
  year: 2015
  ident: 10.1016/j.pcad.2019.11.009_bb0300
  article-title: Untreated masked hypertension and subclinical cardiac damage: a systematic review and meta-analysis
  publication-title: Am J Hypertens
  doi: 10.1093/ajh/hpu231
– volume: 25
  start-page: 525
  issue: 8
  year: 2003
  ident: 10.1016/j.pcad.2019.11.009_bb0665
  article-title: Effects of calcium channel antagonists on left ventricular hypertrophy and diastolic function in patients with essential hypertension
  publication-title: Clin Exp Hypertens
  doi: 10.1081/CEH-120025336
– volume: 19
  start-page: 1167
  issue: 6
  year: 2001
  ident: 10.1016/j.pcad.2019.11.009_bb0670
  article-title: Regression of left ventricular hypertrophy in human hypertension with irbesartan
  publication-title: J Hypertens
  doi: 10.1097/00004872-200106000-00023
– volume: 23
  start-page: 1190
  issue: 11
  year: 2010
  ident: 10.1016/j.pcad.2019.11.009_bb0215
  article-title: Differences of myocardial systolic deformation and correlates of diastolic function in competitive rowers and young hypertensives: a speckle-tracking echocardiography study
  publication-title: J Am Soc Echocardiogr
  doi: 10.1016/j.echo.2010.07.010
– volume: 110
  start-page: 445
  issue: 3
  year: 2012
  ident: 10.1016/j.pcad.2019.11.009_bb0145
  article-title: Meta-analysis of accuracy of left ventricular mass measurement by three-dimensional echocardiography
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2012.03.046
– volume: 136
  start-page: 440
  issue: 5
  year: 2017
  ident: 10.1016/j.pcad.2019.11.009_bb0565
  article-title: Effect of intensive blood pressure lowering on left ventricular hypertrophy in patients with hypertension
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.117.028441
– volume: 5
  start-page: 543
  issue: 8
  year: 2017
  ident: 10.1016/j.pcad.2019.11.009_bb0440
  article-title: The transition from hypertension to heart failure: contemporary update
  publication-title: JACC Hear Fail
  doi: 10.1016/j.jchf.2017.04.012
– volume: 14
  start-page: 13
  issue: 1
  year: 2012
  ident: 10.1016/j.pcad.2019.11.009_bb0260
  article-title: Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy
  publication-title: J Cardiovasc Magn Reson
  doi: 10.1186/1532-429X-14-13
– volume: 122
  start-page: 578
  issue: 4
  year: 2018
  ident: 10.1016/j.pcad.2019.11.009_bb0510
  article-title: Effect of systemic hypertension with versus without left ventricular hypertrophy on the progression of atrial fibrillation (from the Euro Heart Survey)
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2018.04.053
– volume: 153
  start-page: 42
  issue: 1
  year: 2007
  ident: 10.1016/j.pcad.2019.11.009_bb0625
  article-title: The antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT) heart failure validation study: diagnosis and prognosis
  publication-title: Am Heart J
  doi: 10.1016/j.ahj.2006.10.012
– volume: 272
  start-page: 33
  issue: 1
  year: 1994
  ident: 10.1016/j.pcad.2019.11.009_bb0525
  article-title: Left ventricular mass and risk of stroke in an elderly cohort. The Framingham Heart Study
  publication-title: JAMA
  doi: 10.1001/jama.1994.03520010045030
– volume: 19
  start-page: 1550
  issue: 7
  year: 1992
  ident: 10.1016/j.pcad.2019.11.009_bb0025
  article-title: Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension
  publication-title: J Am Coll Cardiol
  doi: 10.1016/0735-1097(92)90617-V
– volume: 36
  start-page: 312
  issue: 2
  year: 2019
  ident: 10.1016/j.pcad.2019.11.009_bb0165
  article-title: Automated, machine learning-based, 3D echocardiographic quantification of left ventricular mass
  publication-title: Echocardiography
  doi: 10.1111/echo.14234
– volume: 371
  start-page: 993
  issue: 11
  year: 2014
  ident: 10.1016/j.pcad.2019.11.009_bb0635
  article-title: Angiotensin–Neprilysin inhibition versus Enalapril in heart failure
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1409077
– volume: 23
  start-page: 290
  issue: 3
  year: 2010
  ident: 10.1016/j.pcad.2019.11.009_bb0315
  article-title: Additive interaction of metabolic syndrome and chronic kidney disease on cardiac hypertrophy, and risk of cardiovascular disease in hypertension
  publication-title: Am J Hypertens
  doi: 10.1038/ajh.2009.253
– volume: 61
  start-page: 187
  issue: 2
  year: 2013
  ident: 10.1016/j.pcad.2019.11.009_bb0475
  article-title: Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2012.10.012
SSID ssj0015077
Score 2.6438878
SecondaryResourceType review_article
Snippet Hypertension (HTN) is a major modifiable risk factor for cardiovascular disease (CVD) morbidity and mortality. The left ventricle (LV) is a primary target for...
AbstractHypertension (HTN) is a major modifiable risk factor for cardiovascular disease (CVD) morbidity and mortality. The left ventricle (LV) is a primary...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 10
SubjectTerms Anti-hypertension therapy
Antihypertensive Agents - therapeutic use
Blood Pressure - drug effects
Cardiovascular
Humans
Hypertension
Hypertension - diagnosis
Hypertension - mortality
Hypertension - physiopathology
Hypertension - therapy
Hypertrophy, Left Ventricular - diagnostic imaging
Hypertrophy, Left Ventricular - mortality
Hypertrophy, Left Ventricular - physiopathology
Hypertrophy, Left Ventricular - prevention & control
Left ventricular geometry
Left ventricular hypertrophy
Remodeling
Risk Factors
Risk Reduction Behavior
Treatment Outcome
Ventricular Function, Left - drug effects
Ventricular Remodeling - drug effects
Title Left ventricular hypertrophy and hypertension
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0033062019301434
https://www.clinicalkey.es/playcontent/1-s2.0-S0033062019301434
https://dx.doi.org/10.1016/j.pcad.2019.11.009
https://www.ncbi.nlm.nih.gov/pubmed/31759953
https://www.proquest.com/docview/2317961460
Volume 63
WOSCitedRecordID wos000521520900004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals 2021
  customDbUrl:
  eissn: 1532-8643
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0015077
  issn: 0033-0620
  databaseCode: AIEXJ
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9swFBZpO0Zfxu5LtxUP1ifjYMuWbT2G0tKNJQs0jOxJyLJM02VOSNzSf7C_vXMs2Um7trvAXkxsrMg-5_PRJ-lcCHnPCqn8PKae4jr1IkVzjwOt9XSWgMJhiJeBrItNJMNhOpnwUafzo4mFuZwlZZleXfHFf1U1XANlY-jsX6i7_VO4AL9B6XAEtcPxjxT_SReVi16M9dKeXLpnMNVcVss5CLTeKjDn6LhuVWK56QhdtdDwoWv6dTdVu43T8u-vWEu7Xnoe6LPv6xjqz98qWWutj1fdfnFwyA748bRF4Cmu1dkoIcwJOZu5J71W6dOZqTDVhPu7X3qbqxLUv7Eq0YbLXPPmrAvH-TE1GzG6sbhgkmOTq6kxydbmbULP2FfrAqutsb11DDDLEee9hZKYCjbgPUzT6vP1iNf6IZ7iE-EDAY3FRIfRFtmhCeNgHnf6H44mH9sNKaDNJv2qfQMbf2VcBW_2dBfHuWsOU3OZ8WPyyE5CnL4BzxPS0eVT8nBg3SyeEQ8x5GxgyNnAkAMYcjYx9JyMj4_GhyeeravhqSimlQcUjfMswmqMmLoo5mGYRIWf5rTIdZoUAdV-VsRZrnmsMqaSkCm09aFmaSZV-IJsl_NSvyIOZTlneUojyfIIqK8sMFuSMpVomYy6JGgEIZTNOY-lT2aicS48Fyg8gcKDyagA4XWJ27ZZmIwr994dNvIVTSwxjH4CwHBvq-S2Vnplv-OVCMSKCl_8ApAuYW1Ly1EN9_xtj-8a5Qsw4LgrJ0s9v1gJmGAlHEhy7HfJS4OK9r2R3HPOwr1_7PU12V1_nG_IdrW80G_JA3VZTVfLfbKVTNJ9i3Q4G44GPwGsAcjF
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Left+ventricular+hypertrophy+and+hypertension&rft.jtitle=Progress+in+cardiovascular+diseases&rft.au=Yildiz%2C+Mehmet&rft.au=Oktay%2C+Ahmet+Af%C5%9Fin&rft.au=Stewart%2C+Merrill+H.&rft.au=Milani%2C+Richard+V.&rft.date=2020-01-01&rft.pub=Elsevier+Inc&rft.issn=0033-0620&rft.eissn=1532-8643&rft.volume=63&rft.issue=1&rft.spage=10&rft.epage=21&rft_id=info:doi/10.1016%2Fj.pcad.2019.11.009&rft.externalDocID=S0033062019301434
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0033-0620&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0033-0620&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0033-0620&client=summon